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ABSTRACT
QUANTITATIVE METHODS FOR GUIDING EPILEPSY SURGERY FROM
INTRACRANIAL EEG
John M. Bernabei
Brian Litt
Despite advances in intracranial EEG (iEEG) technique, technology and
neuroimaging, patients today are no more likely to achieve seizure freedom after epilepsy
surgery than they were 20 years ago. These poor outcomes are in part due to the difficulty
and subjectivity associated with interpreting iEEG recordings, and have led to widespread
interest in developing quantitative methods to localize the epileptogenic zone. Approaches
to computational iEEG analysis vary widely, spanning studies of both seizures and
interictal periods, and encompassing a range of techniques including electrographic signal
analysis and graph theory. However, many current methods often fail to generalize to new
data and are sensitive to differences in pathology and electrode placement. Indeed, none
have completed prospective clinical trials. In this dissertation, I develop and validate tools
for guiding epilepsy surgery through the quantitative analysis of intracranial EEG.
Specifically, I leverage methods from graph theory for mapping network synchronizability
to predict surgical outcome from ictal recordings, and also investigate the effects of
sampling bias on network models. Finally, I construct a normative intracranial EEG atlas
as a framework for objectively identifying patterns of abnormal neural activity and
connectivity. Overall, the methods and results of this dissertation support the
implementation of quantitative iEEG analysis in epilepsy surgical evaluation.
v
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CHAPTER 1: Introduction
Epilepsy is the most common serious neurologic disorder, affecting over 60 million
individuals worldwide, and is characterized by the occurrence of seizures and broad
neurologic dysfunction which contribute to disability, morbidity, and mortality1. Over 1/3
of all people living with epilepsy have seizures which are resistant to antiepileptic
medication, and thus may be candidates for epilepsy surgery to give them a chance at
seizure freedom1. However, epilepsy surgery is often plagued by poor outcomes both due
to seizure relapse, as well as neurologic, cognitive, and psychiatric issues which arise from
the resection of brain in the pursuit of seizure freedom2. One of the main contributors to
seizure relapse is the difficulty in selecting surgical candidates and anatomic targets for
surgery. Intracranial EEG (iEEG) in which direct seizure recordings are made from
implanted electrodes is one of the primary ways epilepsy surgery is guided3. However, its
interpretation is difficult and subjective. In this thesis, I aim to develop and validate
methods for guiding epilepsy surgery through the quantitative analysis of iEEG. After
providing a background on previous quantitative iEEG methods in Chapter 2, I organize
my contributions to this field in the following sections:
Section 1: Map epileptic networks through analysis of pre-ictal and ictal recordings
In the first section, comprising Chapter 3, I validate a method known as virtual
resection4 for mapping the synchronizing nature of regions across the brain. Virtual
resection leverages the use of a metric from graph theory known as synchronizability,
which quantifies the ease with which oscillations can propagate through a network of
coupled oscillators5,6. I compute functional network connectivity during pre-ictal and ictal
1

epochs in 28 patients with drug-resistant epilepsy implanted with subdural grid, strip, and
depth electrodes. I show that time-varying synchronizability can accurately predict surgical
outcome before resection is performed. We also calculate the contribution of each node to
network synchronizability through simulating its removal, yielding a value known as
control centrality. Finally, I illustrate the potential use of synchronizability and control
centrality as a clinical tools that could help select optimal surgical candidates and target
resection to the parts of the brain that are most likely to cause seizures.
Section 2: Understanding the effects of sampling bias on network models
In the second section, I assess the different ways in which spatial sampling bias
affects network models. Intracranial EEG electrode implants vary widely across patients
and centers, with a variety of channel numbers, electrode types, and electrode locations.
However, it is unknown how these differences in sampling propagate into network models
and whether some approaches are only suited for certain types of implantation strategies.
In Chapter 4, I first determine how different network metrics from graph theory have
distinct ways in which they are affected by electrode placement and number of electrodes.
In Chapter 5, I then determine how the two main methods of intracranial EEG, ECoG in
which there are subdural electrodes and SEEG in which there are depth electrodes alone,
have distinct sampling biases which affect the use of network models in epilepsy.
Section 3: Mapping epileptic networks through interictal analysis
In the final section, consisting of Chapter 6, I construct an atlas of interictal
intracranial EEG data. While approaches in neuroimaging benefit from the ability to scan
healthy controls to map differences between normal and abnormal brains, exceedingly few
2

patients without epilepsy receive intracranial EEG. Furthermore, the confounds of normal
neural activity and connectivity present a challenge for traditional forms of interictal iEEG
analysis. Thus, I aggregate data across >160 patients with intracranial EEG and carefully
separate channels which are normal from those which can generate spikes and seizures,
and map normal activity and connectivity throughout the brain. Comparing features of
activity and connectivity in held-out, test patients to those of the normative atlas identifies
abnormalities in neural activity and connectivity associated with patient-level brain regions
which are likely to generate spikes and seizures. I validate the clinical utility of this
normative atlas mapping approach and illustrate how it can be used to guide epilepsy
surgery from intracranial EEG.
Overall, this thesis represents a broad series of studies which address major
challenges in quantitative iEEG analysis for epilepsy surgery, however there is still much
more work to be done. In Chapter 7, I conclude and highlight areas for additional research
which may lay the groundwork for clinical trials in the near future. Ultimately, it is my
hope that this research may soon support the use of quantitative iEEG models in patient
care, improving accessibility and surgical outcomes for drug resistant epilepsy.
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CHAPTER 2: Background
Patients with drug-resistant epilepsy often do not achieve seizure freedom after
epilepsy surgery2,7. When no brain lesion is evident on MRI imaging, the rate of surgical
success is lower still2. Resections can be generous, with a significant amount of healthy
tissue

removed,

frequently

resulting

in

post-surgical

side

effects,

including

neuropsychological deficits and reduced quality of life8. Even when intracranial EEG
(iEEG)9 and brain mapping are performed with the goal of localizing seizures and avoiding
eloquent cortex, it is often unclear where to intervene to optimize outcome while
minimizing tissue destruction and its impact on quality of life8,10. The chief purpose of
iEEG is to localize the ‘epileptogenic zone’ (EZ), which is the minimal amount of cortex
that must be removed to produce seizure freedom11. This theoretical brain area (there could
be more than one) may overlap with the ‘irritative zone’, the region(s) responsible for
generating interictal spikes, as well as the seizure onset zone (SOZ) - the part of the brain
where clinical seizures are observed to originate12. While there is a large body of research
exploring whether mapping the irritative zone through localizing interictal spikes can guide
surgery13–18, current clinical practice primarily aims to define the epileptogenic zone, the
region that must be disabled to stop seizures, by proxy, through identifying all potential
seizure onset zones. However, given the spatial sparsity of iEEG sampling, a limited 2-3
week period for iEEG monitoring, and the ambiguity of manually interpreting iEEG, parts
of the EZ could go undetected and left out of the surgical plan. Thus it is critically important
to develop better, quantitative ways of estimating the boundaries and topology of the
epileptogenic zone.
4

Epileptologists normally evaluate iEEG through an interpretation of temporal,
spatial, and spectral aspects of the signal (Figure 2.1A). The primary method of SOZ
identification is the qualitative recognition of specific seizure onset patterns that are known
to indicate a well-localized onset19,20. Common patterns include (i) low voltage fast activity
(LVFA) in which low-amplitude activity in the beta to low gamma frequency range begins
in a localized area before the propagation of seizure activity elsewhere, (ii) ‘DC shift’ or
‘diffuse electrodecremental event’ which is characterized by a slow shift in baseline
voltage and is often followed by LVFA19, (iii) preictal rhythmic spiking of low frequency
and high amplitude, and (iv) bursts of polyspikes or spike-and-wave activity. However,
seizures in some patients might not display any of these patterns, and conversely, the
presence of these patterns in some channels does not mean that other brain regions are not
epileptogenic. Unfortunately these patterns are frequently appreciated by their absence in
specific patients, replaced by poorly localized, lower frequency or “propagated” patterns,
leaving clinicians to wonder if the implant has somehow missed the region driving seizures,
or if the network is “diffuse,” and better treated with broader neuromodulation than focal
intervention. These limitations of qualitative iEEG analysis often make it difficult for
epileptologists and neurosurgeons to create a surgical plan and can lead to poor patient
outcomes. Many groups therefore hypothesize that quantitative methods of mapping the
EZ that extend beyond visually identifying seizure onset patterns might be able to provide
better surgical targets or offer complementary information that is currently missed.

5

Figure 2.1. Overview of localization of the epileptogenic zone. A) Currently, the
epileptogenic zone is localized from intracranial EEG by evaluation of electrographic
patterns such as low voltage fast activity, DC shift, rhythmic waves, bursts, and spikes.
B) Quantitative methods of ECoG analysis range can range from univariate signal
processing analyses of individual channels, to bivariate analyses on pairs of channels,
and to networks in which connectivity between all pairs of channels are assessed and
emergent network properties are studied. C) In studies of quantitative localization
methods, the value of metrics within the resection zone are compared to those values
outside of the resection zone, and the result is correlated to surgical outcome.
The past two decades demonstrate a growing interest in mapping epileptogenic
zones using quantitative techniques (Figure 2.1B). To date, many of these models follow a
similar paradigm (Figure 2.1C). Ictal or interictal iEEG from a retrospective cohort of
patients is used to calculate the quantitative metric of choice for each channel (referential
or bipolar, corresponding to one or two electrode contacts, respectively) over a specified
time window. When the value of this proposed localizing metric exceeds a certain
threshold, the sampled brain region is deemed pathologic. Finally, one or two hypotheses
are tested: (i) Good outcome patients have a greater proportion of ’pathologic’ channels
resected than poor outcome patients, and (ii) a potential resection zone defined by resecting
6

‘pathologic’ channels has better overlap with the true resection zone in good outcome
patients compared to poor outcome patients. Beyond this general paradigm, the quantitative
methods for identifying the EZ vary greatly, ranging from linear signal analysis to
networked dynamical systems. It is my goal here to review the scope of available
quantitative iEEG methods for localizing the EZ ranging from simple to complex, describe
the retrospective literature supporting the utility iEEG methods, and discuss the path
forward to clinical translation for the benefit of future patients with drug resistant epilepsy,
so that surgical outcomes may be improved.
It is important to note that the above paradigm has suffered from uncertainty in
electrode localization and delineation of the region of brain resected, ablated or modulated
by therapy. Early studies localized electrodes using estimation by surgeons and
neurologists, and resections were crudely measured during the surgery. In more recent
years, robot-guided implants21 and improved methods for coregistering electrodes using
pre and postoperative imaging have dramatically improved precision in this area, though
deformation of the brain during these often lengthy procedures may degrade actual
electrode placement. Similarly, automated methods for segmenting post-resection images
are increasing the accuracy of delineating resected or ablated brain regions, but there is a
growing appreciation that both local and remote effects of these interventions22, in part
related to surgical approach and technique, may vary significantly between centers and
individuals even for the same procedure. Such variability, without quantitation, makes
challenges studies of the effects of different iEEG localizing techniques and their effect on
outcome.
7

2.1 Quantitative electrographic analysis
The transition from analog to digital EEG in the 1980s and 1990s stimulated
researchers to develop quantitative methods analyzing iEEG23. Many of the early studies
focused on signal morphology and frequency content to characterize spiking activity24 or
quantify seizure onset patterns25 in their interpretation of iEEG. A dramatic increase in
computational power and digital storage rapidly emerged, followed by the steady creation
of analysis software, toolboxes for EEG and digital signal processing, and more recently
dynamic, open source packages on multiple platforms for signal processing, nonlinear
dynamics, machine learning, and deep learning. Consequently the field has exploded,
leveraging a wide variety of techniques ranging from analyzing signals from each electrode
contact individually with univariate measures to bivariate metrics that relate signals from
pairs of electrode contacts. While the plurality of methods cannot be covered here, I
describe major divisions in the field and highlight the techniques which have generated the
greatest amount of interest and which I believe carry the most potential clinical utility.
2.1.1 Univariate measures
The simplest univariate approaches to quantitative iEEG evaluation use univariate
linear signal analysis, which comprise a variety of common techniques in the time and
frequency domains (Figure 2.2). For example, the time domain metric of absolute value of
the signal slope, also known as line length26, can correctly identify electrode contacts which
were surgically targeted in good outcome patients27. In the frequency domain, calculating
power within physiological frequencies28 of the delta, theta, alpha, beta, and gamma bands
provides a simple and clinically interpretable manner of quantifying the activity at each
8

node. For example, interictal delta bandpower from iEEG lateralizes the pathologic
hippocampus in mesial temporal lobe epilepsy with good accuracy29, and localized activity
within 20-80 Hz portends good clinical outcome25. Beyond calculating the bandpower of
canonical frequencies, more complicated methods such as the wavelet transform can
transform EEG from each channel into time-frequency plots in which much more granular
detail about the activity at each frequency is readily available. Grinenko et al. used a
wavelet transform of the SEEG signals recorded on each individual channel in patients that
became seizure free to identify a ‘fingerprint of the epileptogenic zone’30,31. They observed
that the EZ is characterized by pre-ictal spikes, multiband fast activity, and suppression of
low frequencies at onset, and used approaches from computer vision to extract features
from the time-frequency plot which were fed into a support vector machine classifier30.
This approach yielded a positive predictive value of >90% for determining which
electrodes fell within the resection zone in good outcome patients and could be a promising
technique in future surgical planning. Overall, the use of linear signal analysis can provide
simple and interpretable quantifications of iEEG signal properties.

9

Figure 2.2. Univariate studies. A) Linear univariate metrics include those in the (i)
time and (ii) frequency domains. B) Non-linear metrics, such as the Epileptogenicity
Index, can identify epileptogenic tissue.
More complicated, non-linear univariate metrics that have seen substantial study
include the epileptogenicity index (EI)32 and epileptogenicity maps (EM)33, which attempts
to quantify clinically-observable patterns based on both the spectral and temporal delay
patterns of iEEG. To calculate the EI, two specific metrics are calculated over a sliding
window: (i) the ‘ER’ ratio of high frequency activity (beta and gamma bands) to low
frequency activity (theta and alpha bands) and (ii) a cumulative sum algorithm used over
the ‘ER’ signal to determine when it significantly changes, marking a shift from low
frequency to high frequency activity. Thus, a channel which is involved early in the seizure
will have a high EI value. EI was initially studied in mesial temporal lobe epilepsy sampled
by SEEG32 and is among the best characterized quantitative iEEG analysis methods with
validation in epilepsy localized to cavernous angiomas34, motor systems35, and occipital
networks36. In all cases it has yielded meaningful localization accuracy and could serve as
a powerful addition to the current paradigm for surgical planning.
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2.1.2 Bivariate Measures
Bivariate iEEG analyses determine the statistical relationships between pairs of
channels and can be analyzed either in isolation or can be employed to construct network
adjacency matrices, where the i,jth matrix entry holds the metric value calculated using
channels i and j. Approaches to bivariate analysis span linear techniques in the time domain
and frequency domain to nonlinear methods adapted from information theory. As
examples, I review correlation, coherence, and phase locking, which are among the most
commonly used metrics for both network and studies and bivariate electrographic analysis
(Figure 2.3).
Perhaps the most prevalent bivariate metric for iEEG analysis is Pearson crosscorrelation, which quantifies the linear relationship between two signals in the time domain
for a given time lag. Spatial changes in seizure activity can be quantified by mapping how
the correlation coefficient between each pair of channels evolves over time in pre-ictal and
ictal epochs. For example, decorrelation across channels at seizure onset is evident in
epileptic fast iEEG activity37. The correlation coefficient can also distinguish patients who
become seizure free from those who do not, as an abundance of small, homogeneous
correlations between channels in temporal lobe epilepsy (TLE) portends good outcome
whereas large, heterogeneous correlations do not38.

In sum, cross-correlation is a

foundational method for assessing connectivity and, independent from network analysis,
may have significant explanatory value for how the activity across brain regions can be
linked.
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Figure 2.3. Bivariate studies. Electrographic analysis that takes data from pairs of
electrode contacts to gauge functional connectivity between regions include metrics
such as Pearson cross-correlation, coherence, phase-locking, and the directed transfer
function. Pearson cross-correlation functions in the time domain, coherence in the
frequency domain.
The frequency domain version of correlation is known as coherence, which
quantifies the linear relationship of the power spectra of two signals in the frequency
domain. Comparing ictal coherence between pairs of electrode contacts in the medial
temporal lobe versus pairs in the lateral temporal lobe can accurately distinguish between
mesial and lateral temporal lobe epilepsy39, which can often be a difficult classification to
determine. Similarly, a study of partially directed coherence in patients with focal cortical
dysplasia found different connectivity patterns between cortical regions beyond the
dysplasia that can generate seizures, which could serve as an important method to find less
obvious EZ locations40. Finally, high ictal coherence in frequency bands exhibiting high
frequency oscillations (HFOs) has been shown to be an EZ biomarker and tends to spatially
focus in clusters of channels associated with seizure onset regions41. The ability for
coherence to selectively assess activity in specific frequency bands may provide significant
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value towards increasing our understanding of seizure dynamics as well as identifying the
modes of neural synchrony which are most pathogenic.
A third commonly used bivariate metric is phase locking value (PLV), which
describes the absolute value of the phase difference between two signals, and has been
frequently used to search for epileptogenic zones. The driving factor behind this statistic is
that areas of the brain capable of generating seizures may induce changes in long range
synchronization that are visible by examining phase. High-gamma band phase locking to
low frequency channels is a putative feature of the ictal core and when used as a method
of EZ localization can accurately predict surgical outcome, with an area under the receiveroperating characteristic curve of 0.79, versus 0.68 for using the SOZ alone42. Phase-locking
from high gamma to low frequencies was used in a logistic regression model to predict the
EZ43. 96% of the channels identified using this approach were resected in good outcome
patients, while over 31% of the identified channels fell outside of the resection zone in poor
outcome patients. With multiple successful retrospective studies, phase-locked high
gamma may be a good candidate for prospective studies in localizing the EZ.
Finally, directed connectivity metrics have also provided essential insight into the
relationship of the EZ and the surrounding brain and could serve as important localizing
tools. In particular, partial directed coherence (PDC) and the directed transfer function
(DTF) have revealed that the EZ has unexpectedly high inward connectivity compared to
other parts of the brain, however outwards strengths are not different44. Using these
measures as inputs to a classifier for determining epileptogenic regions yielded an area
under the curve of 0.88, and increased to 0.93 when restricted to the EZ of only good
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outcome patients. The finding of enhanced inwards connectivity could be possibly due to
an ‘inhibitory surround’ which could be attempting to suppress epileptiform activity45. In
the future, it is likely that directed connectivity measures could be used in surgical
evaluation for their simplicity, interpretability, and localizing value.
2.2 Network methods
There is an increasing body of evidence supporting the hypothesis that epilepsy is
a disease of disordered brain networks46–48. Generalizing the basis of bivariate
electrographic signal analysis to measure functional connectivity leads us to the essentials
of network neuroscience49. Using statistical metrics we can define network ‘nodes’ as brain
regions recorded by single or groups of iEEG electrodes and ‘edges’ as the relationship
between nodes50. Any bivariate metric including correlation, coherence, mutual
information, and phase locking value can be used to calculate edge weights and yield a
functional connectivity (FC) matrix. Networks can be calculated during interictal or ictal
epochs, and EEG can be windowed before network calculation to yield multilayer networks
which can quantify network dynamics over time. These principles give rise to a wide
variety of EZ localization methods, some which study patterns of connectivity in a modelfree fashion, and others which use neural models to overlay dynamics on top of
connectivity (Figure 2.4).
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Figure 2.4. Network studies. Networks can be constructed from bivariate metrics to
quantify the connectivity between all possible pairs of electrodes, and these adjacency
matrices can be used towards graph studies or other models. A) Model-free network
studies can use nodal metrics like node strength, betweenness centrality, and
eigenvector centrality. They can also use global metrics like efficiency, path length, and
synchronizability. B) Model-based methods can use connectivity to parametrize
dynamical systems. In many studies, the dynamical systems generate surrogate EEG
which can be assessed for its probability of being in an ‘ictal-like’ state, such as in
Goodfellow et al and Sinha et al.

2.2.1 Model-free approaches
The simplest network neuroscience paradigms for quantitative localization of the
EZ use ‘model free’ approaches which apply traditional statistics that describe different
aspects of network structure. The bulk of these metrics were developed outside of the
framework of neuroscience and have been well-studied and characterized in the fields of
physical, social, and information networks. The simplest model-free network method for
EZ localization is using a metric known as ‘degree’ for binary networks or ‘node strength’
for weighted networks, which is the sum of all a given node’s connections. Node strength
is a simple yet powerful metric for surgical targeting, as the EZ has high interictal intrazone connectivity and connectivity to outlying brain in both SEEG51 and ECoG52. These
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significant findings warrant further study, as the ability to define the boundaries of the EZ
using simple interictal network measures alone would obviate the need for a lengthy and
costly hospital stay for the purpose of recording seizures.
Node-level centrality metrics capture the relationship between each node and local
or global patterns in the network. For example, betweenness centrality quantifies the
number of shortest paths that are routed through a given node, and is higher in the resection
zone of good outcome versus poor outcome patients53. A similar metric known as
eigenvector centrality estimates the influence of each node on the entire network based on
the eigenstructure of the network adjacency matrix. Burns et al54 found eigenvector
centrality to be higher in resected regions in good outcome versus poor outcome patients.
Another method that quantifies a type of centrality is known as ‘virtual resection’4,55, in
which network synchronizability estimates the stability of the fully synchronous state, and
control centrality, which is the contribution of each node or brain region to
synchronizability. Our group has used these metrics to distinguish seizure types4, predict
surgical outcome55, and identify surgical targets by mapping out synchronizing and
desynchronizing regions of the network.
To quantify patterns that extend beyond the individual node or edge level, a variety
of techniques exist for studying medium and large scale network structure56. One such
technique, non-negative matrix factorization (NMF)57,58, can deconstruct the network
adjacency matrix into sub-graphs which have time-varying coefficients and together sum
to the full network activity. Performing NMF is able to uncover patterns in connectivity
that represent the seizure onset zone in both interictal and ictal time frames59. Furthermore,
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ictal and interictal sub-graphs have similar topologies which may provide methods for
determining good surgical targets. Another study determined that epileptic brain networks
have ‘rich club’ structure characterized by high connectivity nodes that themselves were
highly connected to each other60, and that resecting more of the ‘rich club’ population leads
to better surgical outcome. Assessing broad network properties may serve as a powerful
method of both understanding the influence of brain networks on epileptic activity as well
as guiding surgical intervention.
2.2.2 Model-based approaches
In contrast to traditional network metrics, functional connectivity derived from
iEEG can be used to weight links between neural mass models (NMM) which use
principles from dynamical systems to simulate epileptic activity. In a NMM, a small
number of variables representing excitatory or inhibitory currents affect the state or mean
field of a neural population, typically at the scale of columns or cortical areas. There exist
a wide variety of neural mass models that have been thoroughly studied in epilepsy37,61–63,
but there exists a common underlying theme. Each node, representing a local population
of neurons, can inhabit one of two states representing interictal and ictal activity, and
stochastic input from internal or external sources drives switching between states.
Dynamical modeling has the potential advantage of better clinical interpretability when
compared to model-free network approaches as it provides the ability to perturb the
network model. Perturbations can simulate the consequences of different resection or
ablation interventions, which could be a useful in surgical planning in the case that the
primary hypothesis lies in eloquent cortex64.
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Sinha et al65 used this principle and assigned each brain region a differential
equation that governed a dynamical system. They calculated average interictal correlation
between pairs of channels to derive a functional connectivity matrix which they used to
link neural mass models. They used the hypothesis that transition between the bistable
states of non-seizure and seizure is caused by stochastic noise. The authors measured the
time to seizure transition for each node, and defined the EZ by identifying nodes which
quickly transitioned into seizures. They showed that these nodes are more often resected
in good versus poor outcome patients, and they were able to use this model to identify
potential surgical targets and predict outcome. They provided an important validation step
of showing that this model performed better than just purely identifying nodes with high
strength of weighted connections. It is promising that excellent performance can be
achieved using interictal recordings alone, and the approach in this paper may be a good
candidate for future clinical translation.
Another well-characterized phenomenological model known as brain network
ictogenicity (BNI) carries significant promise for planning epilepsy surgery66. Rather than
attempting to simulate seizures, the BNI paradigm simulates spiking activity using the
Wendling model67, a set of twelve ordinary differential equations that quantify postsynaptic potentials at each node and has been shown to replicate seizure dynamics68. Each
neural population can range from quiet to active, in which it generates discharges. To
determine connection weights between the neural mass models at each node, they
calculated mutual information from patient ECoG during clinical seizures. The authors
define BNI as the fraction of time the model spends in the discharge state, and showed that
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high NI nodes were more likely to be removed in patients that became seizure free after
surgery compared to poor outcome patients. They also showed high ∆BNI in good outcome
versus poor outcome patients, which gives evidence for this model’s utility in both
predicting surgical outcome as well as identifying putative targets.
2.3 The path forward
While many of the methods I have discussed here show early promise in
retrospective studies, the path forward requires that clinicians trust quantitative results and
learn to integrate their findings into the clinical workflow. These methods will not replace
traditional iEEG evaluation entirely but rather will likely serve as additional data for
clinicians to consider when identifying surgical targets for epilepsy surgery. In this section
I discuss a few significant points towards improving previous models and moving towards
clinical translation (Figure 2.5).
2.3.1 Generalizability
A critical aspect of any model is its ability to generalize to new data on which it
was not developed. In the field of EZ localization, one chief barrier to generalizability is
differences in electrode recording paradigms. Historically, centers in the United States have
favored electrocorticography though grid and strip electrodes (ECoG) while centers in
France and Italy have favored stereotactically implanted depth electrodes (SEEG). ECoG
usually samples a restricted amount of cortical surface on one hemisphere with a regular
interelectrode spacing such as on a typical grid array, whereas SEEG typically records from
more distributed brain regions in a sparse manner using a number of individual depths to
sample deep structures and white matter which are inaccessible to ECoG. These differences
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in spatial sampling might not cause significantly different results of univariate
electrographic methods, but could greatly affect bivariate functional connectivity and
subsequent network analyses, which depend on interelectrode distance and the underlying
connectivity patterns between distant brain regions. Thus, translating EZ localization
methods from ECoG to SEEG or vice-versa should be done with care and may require
methodological modification in many instances.

Figure 2.5. The path forward. A) Generalizing current studies of EZ localization
methods will require (i) validating methods in both ECoG and SEEG and (ii) accounting
for inter-patient heterogeneity by testing at different centers. B) Data-sharing will be
essential for aggregating enough data to capture less common types and patterns of
seizures for use in future studies. C) Methods must be developed to understand and
account for sampling bias introduced by sparse implantation of electrodes. D)
Multimodal studies which incorporate neuroimaging or MEG with iEEG may be able
to improve models. E) Animal studies could be a bridge from retrospective human
studies to prospective human studies. F) Prospective human studies must eventually be
undertaken.
Another generalizability barrier will be the significant patient heterogeneity that
exists among individuals and across patient populations that are treated by different
epilepsy centers. For example, methods which were developed primarily for patients with
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mesial temporal lobe epilepsy may not generalize well to patients with neocortical disease.
Even within the same epilepsy syndrome, measures that accurately delineate the EZ
boundary of patients with a lesional MRI might not do so in non-lesional patients. Many
centers do not have the ability to acquire large volumes of similar patients and thus many
models will need retrospective validation in cohorts of aggregated patients across centers
before prospective trials can be initiated.
Another area of contention is whether epilepsy surgery aims to resect focal
pathology or intervene upon a broader epileptic network. The approach of signal analysis
lends itself to the hypothesis of a seizure-generating focus by determining which candidate
brain region out of all regions sampled by iEEG is the most pathogenic. On the other hand,
network-based methods of EZ localization seem to favor the idea that epileptic networks
are distributed by considering how the entire brain influences the behavior at a single node
and vice versa, as well as the complicated patterns of seizure initiation and propagation
that could arise out of a disordered network. Advances in experimentation and imaging
may provide evidence for one hypothesis over the other.
2.3.2 Data sharing
Ultimately, the development of a high-quality quantitative method of EZ
localization cannot be completed by a single center alone. This is in part due to the wide
variability across patients as to their clinical disease, intracranial implant characteristics,
and ultimate therapy received. Thus, the path to clinical translation will require broad
collaboration and the investment in resources for data sharing. One such platform is
ieeg.org69,70, an online electrophysiology sharing portal with over 5000 users worldwide
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which houses over 100 public intracranial EEG recordings complete with accompanying
imaging and clinical metadata from the University of Pennsylvania and the Mayo Clinic,
in addition to and thousands of scalp, animal and other human studies. The repository on
ieeg.org is sufficient to support developing quantitative EZ localization methods, however
more multicenter data will be necessary for validation and to prevent overfitting of models
to the most popular and available datasets. While the challenges of open-source science are
significant, the benefits will be invaluable for translating the methods described in this
review towards clinical practice.
2.3.3 Incomplete sampling of brain
Another significant barrier to the clinical translation of quantitative iEEG methods
is the clinical constraint of sparse brain sampling. While the current approach to iEEG
implantation favors testing clinical hypotheses on the location of the EZ with the minimum
number of electrodes possible, quantitative analysis could yield incorrect predictions if the
epileptic network isn’t properly characterized. Preliminary evidence suggests network
metrics have different sensitivities to subsampling on intracranial EEG71, and the predictive
power of personalized network models for epilepsy is improved with a greater number of
nodes72. We need better methods of determining when the network is sufficiently
characterized to deploy quantitative measures with confidence. One possible method of
doing so could be examining concordance of results across models. For example, multiple
neural mass models have concordance with nodal heterogeneity is high, which is known to
be a network feature which is correlated with good outcome. Another method could be
jackknife resampling of electrode contacts to simulate alternate implantations, which could
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generate spatial confidence intervals for localization of EZ based on network models71.
Thus, if resampling the network has a minor influence on the localization, it may mean that
the network is well characterized. Perhaps the best method, however, would be to aggregate
large numbers of recording from patients with similar syndromes and different
interventions and outcomes, to better represent the range of individual expressions of
common medically refractory epilepsy syndromes Further study is needed to validate
methods of confirming sufficient localization and doing so will hasten the deployment of
quantitative iEEG paradigms in clinical practice.
2.3.4 Integration of multimodal data
In order to move beyond the limitations of intracranial EEG analysis such as
sampling bias and to potentially alleviate the need for extensive intracranial implants in the
future, non-invasive measures from MEG, TMS, structural imaging, or functional imaging
may be combined with iEEG analysis. One significant example of this is the virtual
epileptic patient (VEP), which uses diffusion weighted imaging to estimate connection
weights between neural mass models which are tuned to closely approximate the seizure
activity in each individual patient73. Another method under study is structure-function
coupling in which diffusion imaging is compared with functional imaging or iEEG to
understand how activity propagates through the brain’s underlying connections. However,
methods which alleviate the need for intracranial EEG in patients for which it is currently
indicated remain elusive.
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2.3.5 Clinical trials
The only route to translating quantitative methods of localizing the EZ to patient
care is through clinical trials. However, given the substantial morbidity involved with a
failure of resective or ablative epilepsy surgery, it is difficult to clinically validate EZ
localizing tools. One of most challenging aspects of designing a prospective trial will be
defining the exact application of the candidate model. Will it be used to refine the surgical
resection boundaries once a general brain region target has been established? Or would it
identify candidate resection zones in difficult cases where clinicians are stumped. Currently
in the EPINOV trial for the Virtual Epileptic Patient model, a list of the highest likelihood
targets and their probabilities of lying within the EZ provided to clinicians. Another trial,
currently underway at ICL in London, allows addition of up to 3 additional electrodes to
standard implants, in a controlled, randomized trial of adding quantitative methods to
standard clinical practice to assess their ability to improve patient outcome. As more iEEG
analysis tools reach maturity, more such trials may be initiated and methods can be refined
for the exact clinical scenarios for which they are best suited.
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CHAPTER 3: Analysis of seizure networks
3.1 Abstract
Patients with drug-resistant epilepsy often require surgery to become seizure-free.
While laser ablation and implantable stimulation devices have lowered the morbidity of
these procedures, seizure-free rates have not dramatically improved, particularly for
patients without focal lesions. This is in part because it is often unclear where to intervene
in these cases. To address this clinical need, several research groups have published
methods to map epileptic networks, but applying them to improve patient care remains a
challenge. In this study we advance clinical translation of these methods by: (1) presenting
and sharing a robust pipeline to rigorously quantify the boundaries of the resection zone
and determining which intracranial EEG electrodes lie within it, (2) validating a brain
network model on a retrospective cohort of 28 patients with drug-resistant epilepsy
implanted with intracranial electrodes prior to surgical resection, and (3) sharing all
neuroimaging, annotated electrophysiology, and clinical metadata to facilitate future
collaboration. Our network methods accurately forecast whether patients are likely to
benefit from surgical intervention based on synchronizability of intracranial EEG (area
under the ROC curve of 0.89) and provide novel information that traditional electrographic
features do not. We further report that removing synchronizing brain regions is associated
with improved clinical outcome, and postulate that sparing desynchronizing regions may
further be beneficial. Our findings suggest that data-driven network-based methods can
identify patients likely to benefit from resective or ablative therapy, and perhaps prevent
invasive interventions in those unlikely to do so.
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3.2 Introduction
Epilepsy affects 65 million people, one third of whom are resistant to antiepileptic
medications. In these cases, surgery is often necessary to help reduce seizures10. Resections
can be generous, with a significant amount of healthy tissue removed, frequently resulting
in post-surgical side effects, including neuropsychological deficits and reduced quality of
life8. Unfortunately, some patients have seizure recurrence despite removal of assumed
critical seizure generators, as mapped by extensive electroencephalography, multimodal
neuroimaging, and neuropsychological evaluation prior to surgery10. Due to the limitations
of traditional epilepsy surgery, clinicians are turning to other less destructive therapeutic
approaches. Specifically, responsive neurostimulation, deep brain stimulation, and targeted
laser ablation techniques are increasingly being used to alleviate seizure burden and
improve quality of life74–76. These interventions are hypothesized to act by disrupting
connections and pathways involved in seizure spread76. Identifying these important control
regions is a critical step toward realizing the potential of these newer, less invasive
techniques and for optimizing the use of established resective surgery.
While focal brain lesions have long been a target of epilepsy surgery with favorable
success rates, patients without clear lesions may have seizures that arise from abnormal
connectivity in broader networks that can be measured at the scale of electrocorticography
(ECoG). Recent work supports the hypothesis that epilepsy can arise from disordered brain
networks47. In epileptic networks, the seizure onset zone (SOZ) often not only drives
seizure initiation and propagation, but also recruits regions that extend well beyond it to
act as central hubs. These regions appear to strengthen in connectivity to each other, while
weakening in connectivity to remaining regions77,78. Because the epileptic network may be
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characterized by pathologic foci embedded in this web of structural and functional
connections79, it is important to understand how aberrant cortical functioning drives seizure
dynamics and manifests in the diverse roles of regions such as the epileptogenic, irritative,
and propagation zones. Thus, a network approach that quantifies the complex
synchronization and spread of neural activity is well suited to studying epilepsy in which
changes in brain connectivity manifest across a wide range of spatiotemporal scales.
Recent efforts to translate and extend methods originally developed in network
science have generated novel in silico approaches to model epileptic networks49,54,73 and
identify important regions to target therapeutically with surgical4,52,60,65,66 or non-surgical80
interventions. While some of these models quantify brain dynamics through data-driven
network models4,52,54, others integrate network architecture estimated by intracranial EEG
or imaging with generative mathematical models that parameterize behavior at each
node60,65. The Virtual Epileptic Patient (VEP)73 is one notable model that uses structural
connectivity estimated from diffusion weighted MRI to parameterize coupled ‘Epileptor’
oscillators81 which predict seizure propagation and spread. The VEP framework is
currently being studied in a prospective clinical trial to augment clinician decision making
in epilepsy surgery (US National Library of Medicine, 2018). Previous studies have
established the potential of modeling to enhance our understanding of epileptic networks,
but their translation to clinical care has been challenging. There are multiple potential
reasons for this. Some approaches such as the VEP use models that generate synthetic
seizures that look remarkably similar to clinical events, but because they are synthetic there
is concern that they may not capture the complex interplay between brain regions with
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inherently different control properties. Many studies do not use expert clinical annotations
from interictal, pre-ictal, and seizure epochs to evaluate the full spectrum of epileptic
activity in each patient. Finally, validation has been challenging, particularly for studies
that use clinical data. For a variety of reasons, most groups have not openly shared their
methods and data so that other centers can reproduce and extend their studies. We aim to
specifically overcome each of these shortcomings in this study using the virtual resection
framework developed by our group.
Virtual resection4 implements a brain network model in which the regions measured
by individual intracranial electrode contacts are defined as nodes, and the statistical
relationships between pairs of nodes known as functional connectivity are defined as
edges49. This approach focuses on calculation of synchronizability, which describes the
ease with which neural activity can propagate through the network. Virtual resection uses
a push-pull framework in which synchronizing nodes dynamically oppose desynchronizers
and thus the properties of the network are modulated as a function of time. By virtually
removing nodes and recalculating synchronizability, we quantify each node or region’s
control centrality4 and thus estimate how well dynamic brain activity such as seizures
would spread throughout the network if a given region were removed. While this
framework has been shown to robustly characterize the spatiotemporal regulators of seizure
dynamics4, in our prior work we did not engage in any effort to predict surgical outcomes
nor did we investigate whether control centrality within the resection zone played a key
role in accurately predicting that outcome. In the work presented here, we hypothesize that
removing synchronizing versus desynchronizing brain regions as determined by the virtual
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resection method is predictive of good versus poor outcomes. In addition, we hypothesize
that control centrality within the resection zone is predictive of epilepsy surgical outcomes.
In this multi-center retrospective cohort study, we seek to determine whether virtual
resection network features can predict surgical outcome in 28 patients with drug resistant
epilepsy who underwent surgical therapy. Specifically, we ask: What is the spatiotemporal
evolution of synchronizability during a seizure? Is there a relationship between network
synchronizability and important clinical variables used to guide therapy? What is the
accuracy of predicting surgical outcome from the control centrality of combined group
nodes overlying resection cavities? We hypothesize that virtual resection will uncover
important seizure dynamics as measured by network metrics that can separate patients
based on post-surgical outcome and that network metrics will be sensitive to clinical
variables such as seizure type.
3.3 Materials and Methods
3.3.1 Patient dataset
All patients included in this study gave written informed consent in accordance with
the Institutional Review Board of the University of Pennsylvania. All patients from both
the Hospital of the University of Pennsylvania and the Mayo Clinic gave consent to have
anonymized full-length electrophysiology recordings and brain MRI and CT scans
available to the public on the open online portal IEEG.org69.
Twenty-eight patients undergoing surgical treatment for medically refractory
epilepsy (Table 3.1) underwent implantation of subdural and depth electrodes to localize
the seizure-onset zone after presurgical evaluation with scalp electroencephalogram (EEG)
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recording of ictal epochs, MRI, fluorodeoxyglucose - positron emission tomography
(FDG-PET), and neuropsychological testing. The results of the presurgical studies
suggested that focal cortical resection might be a therapeutic option. Patients were then
implanted with intracranial electrodes including grid, strip and sparse depth electrodes, to
better define the epileptic network. De-identified patient data were retrieved from the
online International Epilepsy Electrophysiology Portal (IEEG Portal). Patients were
excluded from the study if they (1) did not undergo resection, (2) did not have complete
post-resection imaging, or (3) did not have complete electrophysiology data. Surgical
outcome was measured at a minimum of one year after surgery and determined based on
medical records from the last available follow up with a clinician. Patients who had surgical
outcome of Engel I or ILAE 1-2 were marked as having favorable outcome and patients
who had Engel II-IV or ILAE 3-6 were marked as having poor outcome (Wieser et al.,
2001).
ECoG signals for patients from the Hospital of the University of Pennsylvania were
recorded and digitized at 500 Hz sampling rate and pre-processed to eliminate line noise.
Cortical surface electrode configurations, determined by a multidisciplinary team of
neurologists and neurosurgeons, consisted of linear and two-dimensional arrays (2.3 mm
diameter with 10 mm inter-contact spacing) and sampled the neocortex and mesial cortex
for epileptic foci. Signals were recorded using a referential montage with the reference
electrode, chosen by the clinical team, distant to the site of seizure onset and spanned the
duration of a patient’s stay in the epilepsy-monitoring unit. All EEG recording systems and
intracranial electrodes used were FDA approved and commercially available.
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Good surgical
outcome
(Engel I or
ILAE 1-2)
17

Poor surgical
outcome (Engel
II-IV or ILAE 36)
11

36.2 ± 11.1

33.1 ± 18.6

Male
Female

9
8

6
5

LTL
RTL
LFL/LPL/LFPL
RFL/RFTL/RFPL

3
8
4
2

6
1
2
2

Lesional
Non-Lesional

7
9

4
5

HS/MTS
Gliosis
Malformations of cortical development
Tumor/vascular/infection
Seizure Type*
Aura/Focal aware
Focal impaired awareness
Focal w/generalization
Type of resection
Anterior temporal lobectomy and/or
amygdalohippocampectomy
Anterior temporal lobectomy+
Partial resection/lesionectomy
RF ablation
Volume of resection
Volume of tissue (cc)
Mean ± std. dev.
Nodes removed (%)
Mean ± std. dev.

6
3
5
2

2
8
0
0

14
51
31

3
30
11

3 (left), 7 (right)

6 (left), 2 (right)

1 (left)
3 (left), 2 (right)
1 (right)

None
2 (left), 1 (right)
None

Total number of subjects
Age at surgery*

Mean ± std. dev.

Sex
Resected / Ablated region

MRI*
Pathology*

p - value

p = 0.99a
p = 0.93b
p = 0.11b

p = 0.97b
p = 0.02b

p = 0.20b

p = 0.68b

p = 0.83a
19.3 +/- 12.8

23.5 +/- 18.9
p = 0.72a

19.3 +/- 14.4

21.5 +/- 10.8

Table 3.1. Virtual resection dataset. Patients were grouped by surgical outcome.
Second column shows patients that had a favourable surgical outcome. Third column
shows patients that had a poor surgical outcome. FCD = focal cortical dysplasia; HS =
hippocampal sclerosis; LFL = left frontal lobe; LFPL = left frontoparietal lobe; LPL =
left parietal lobe; LTL = left temporal lobe; MTS = mesial temporal sclerosis; PNH =
periventricular nodular heterotopia; RF = right frontal; RFL = right frontal lobe; RFPL
= right frontoparietal lobe; RPL = right parietal lobe; RTL = right temporal lobe; TSC
= tuberous sclerosis complex.
a

T-test; bPearson chi-square test. *Data for these fields were unknown in a minority of
patients and was not thus included in the table.
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3.3.2 Clinical marking of seizure events
Seizure-onset zone was marked on ECoG according to the standard clinical
protocol in the Penn Epilepsy Center. Initial clinical markings are made on IEEG by boardcertified staff epileptologist attendings. These IEEG markings were made by clinicians
blinded to surgical outcome but provided with available surgical conference notes that
contained patient clinical data related to other multimodality testing, such as brain MRI,
PET scan, neuropsychological testing, and ictal single-photon emission computed
tomography (SPECT) scanning, used to finalize surgical approach and planning. The
following seizure times were annotated for each seizure: (1) earliest electrographic change
(EEC)82, (2) unequivocal electrographic onset (UEO), and (3) termination of seizure
(END). A pre-seizure state that spanned a period equal in duration from EEC to END was
used to mark the baseline pre-ictal period for any given seizure. An epileptologist involved
in the study examined the patient’s primary seizure type for the presence of localizing
factors such as low voltage fast activity (LVFA), DC shift, and a clearly focal seizure onset
zone which are known to predict outcome83–86. If a disagreement regarding annotation
arose, at least two epileptologists discussed the seizure in question until reaching
consensus. All seizures were identified according to the current International League
Against Epilepsy (ILAE) classification system, as focal aware seizures, focal impaired
awareness seizures, or focal to bilateral tonic-clonic seizures. When clinical notes were
unclear, the reviewing epileptologist made a decision on seizure type based on all available
clinical data. In order to support the potential generalizability of our methods to any new
patient, network measures were computed on all seizures, interpolated to fit into ten
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sequential time bins spanning the pre-seizure and seizure epochs, and averaged within a
patient's group of seizures.

Figure 3.1. Imaging pipeline for resection zone estimation. The imaging pipeline
registers pre-operative MRI, post-implant CT, and post-resection MRI together in order
to allow for resection zone mapping and electrode localization. In-house software in
addition to ITK-SNAP were used to map resection zones and localize electrodes for all
patients using cartoon maps presented in surgical conference notes. Nodes that
overlapped with the resection zone were virtually resected from the network to measure
effect on synchronizability.

3.3.3 Image Processing
All patients, as part of their clinical neuroradiological workup, underwent a clinical
epilepsy neuroimaging protocol. Pre-implant T1-weighted MPRAGE MRI, post-implant
T1-weighted MPRAGE MRI, and post-implant CT images were acquired in order to
localize electrodes. In addition, patients underwent a post-resection imaging protocol
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acquired on average 6-8 months after implant and resection, which consisted of T1weighted MRI and axial FLAIR MRI sequences. All images were stripped of headers,
anonymized and registered to patient's native pre-implant T1 MRI space for localization
and segmentation (Figure 3.1). In-house software87 was used to assist in localizing
electrodes after registration of pre-implant and post-implant neuroimaging data. All
electrode coordinates and labels were saved and matched with ECoG electrode names on
IEEG.org. All electrode localizations were verified by a board-certified neuroradiologist.
Pre-implant MRI imaging was registered diffeomorphically using the Advanced
Normalization Toolkit (ANTs)88 to post-resection imaging in order to accurately segment
the resection zone. Resection zones were estimated semi-automatically with the use of a
random forest classifier and region-growing algorithm as part of the ITK-SNAP toolkit89.
All resection estimates were confirmed by a board-certified neuroradiologist.
3.3.4 Network methods
The virtual resection method (Figure 3.2) is described in greater detail in
Khambhati et al. Electrodes in which the ECoG signal was obscured by artifact, as noted
by an attending epileptologist, were removed from analysis in order to avoid biasing our
results. A common average reference was applied to all neural signals by first computing
a time-varying signal averaged across all electrodes and then by subtracting this signal
from each electrode. All ECoG signals were notch filtered at 60 Hz to remove power line
noise. We constructed functional brain networks in each time window using multitaper
coherence estimation, which defines an edge between electrode pairs in terms of the
correlation of the power spectra of signal activity over a specific frequency band. This
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procedure was done across different physiological frequency bands, namely: a/q (5 – 15
Hz), b (15 – 25 Hz), low-g (30 – 40 Hz), high-g (95 – 105 Hz) and very high frequencies
(>105 Hz). In addition, broadband cross-correlation was used to generate functional
dynamic networks without regard to frequency specific information. In this study we
compute functional networks directly from clinical recordings of intracranial EEG and not
on modeled or simulated data. These networks were generated as N x N symmetric
adjacency matrices, describing the network for all T time windows.

Figure 3.2. Electrophysiology pipeline for epileptic network analysis. The
electrophysiology pipeline uses coherence to construct adjacency matrices for each
event, separately for seizure and pre-seizure data. Baseline synchronizability of the
network and control centrality of each individual node is calculated. From the imaging
pipeline, resected electrodes are determined, and control centrality of the resection zone
is calculated. Metrics are used to generate predictions of surgical outcome.
Because of its importance to seizure spread, we measured network
synchronizability by first computing the Laplacian matrix of each adjacency matrix at time
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one-second time windows. The Laplacian matrix can be interpreted as measuring the ease
with which information diffuses between nodes in a network5. Next, at each time epoch t
across all T epochs, we calculated the synchronizability measure, s(t) as the ratio of the
second smallest eigenvalue to the largest eigenvalue of the Laplacian matrix which
quantifies the stability of the synchronous state5. In order to model the effects of resective
surgery, we used the approach of virtual cortical resection which quantifies control
centrality as the contribution to synchronizability. Control centrality can be calculated
either at each node or for the entirety of a region of interest by removing the node or nodes
in question from the network and recalculating synchronizability. In this study, we remove
the resection zone en bloc to calculate control centrality when comparing across patients,
while for whole brain visualizations we calculate control centrality at the node level. This
measure of change in synchronizability is referred to as the control centrality, or cres(t), and
can be used to identify a region as (1) desynchronizing (removal of which increases postresection network synchronizability) characterized by positive control centrality, or (2)
synchronizing (removal of which decreases post-resection network synchronizability)
characterized by negative control centrality.
3.3.5 Statistical methods
All averages computed in this study use the median because it represents a better
measure of centrality in skewed, non-normal distributions such as seen in the distribution
of network measures90. We compared median time-varying network metrics between
seizures in patients who experienced a favorable surgical outcome and patients who
experienced a poor surgical outcome. We performed this comparison by normalizing each
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seizure event into ten sequential time bins spanning the pre-seizure and seizure epochs, and
employing functional data analysis (FDA) to statistically test differences in temporal
dynamics between seizure types independently in each state91. FDA allowed us to test
whether the area under the good outcome curves and poor outcome curves were
significantly different by comparing the true area to the area expected in an appropriate
permutation-based null model. The null model was created by re-assigning surgical
outcome to adjacency matrices uniformly at random up to 10,000 times and computing the
median area under the resulting curves of functional network metrics.
The median network measures during pre-ictal epochs are compared to those of
ictal epochs using Wilcoxon rank-sum test. The Ds(t) change from pre-ictal to ictal time
periods was used as the feature for quantifying the ability to predict surgical outcome. We
varied the threshold of Ds(t) to predict patients as having either good or poor surgical
outcome which generated a receiver operating characteristic (ROC) curve. We measured
area under the ROC curve (AUC) as a marker for accuracy in predicting good versus poor
surgical outcome; the ROC curve quantifies the tradeoff between the true positive rate and
the false positive rate for a binary classifier. We used the non-parametric DeLong test to
compare ROC curves and determine whether any single predictive model derived from a
specific frequency band performed significantly better than the others92. In the analysis of
control centrality of the resection zone we present p values noting that the significance
threshold is 0.0083 to correct for six comparisons introduced by the separate frequency
bands according to the Bonferroni method.
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3.3.6 Data availability
Our

codebase

comprises

the imaging

and

electrophysiology

pipelines

(https://github.com/ieeg-portal/EpiVR), and allows researchers to easily fetch data situated
on the IEEG.org portal as well as to perform virtual cortical resection. The
electrophysiology pipeline is dependent on Echobase, which can be found at
https://github.com/akhambhati/Echobase. We have additionally made pre- and postresection imaging as well as annotations of seizures along with their ECoG recordings from
the entirety of their epilepsy monitoring unit (EMU) stay available to the public through
IEEG.org. From this unique and powerful dataset we hope that other investigators may
validate our methods or compare their performance to other virtual resection tools.
3.4 Results
Twenty-eight patients with drug resistant epilepsy underwent implantation with ECoG
electrodes to localize the seizure onset zone preceding surgical resection. Patient specific
network models were constructed from clinically annotated ECoG recordings stored on the
cloud platform IEEG.org69,70, and a quantitative pipeline using pre- and post-surgical
imaging was used to determine which electrodes were resected.
3.4.1 Network synchronizability predicts surgical outcome
We began our virtual resection approach by examining the dynamic network
changes in synchronizability s(t) that occur in the transition state from pre-ictal to ictal
periods. Seizures were interpolated to be equal length across patients and onset times were
aligned such that s(t) curves could be compared. Figure 3.3A shows the time course of
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median broadband synchronizability over pre-ictal and ictal periods between good and poor
outcome patients. These curves were different in the ictal period between outcome groups
(FDA curve area test, 10,000 permutations, p < 0.001) suggesting that there is predictive
information in the magnitude and temporal evolution of s(t). Patients with favorable
surgical outcomes had decreased synchronizability at the time of seizure onset across
frequency bands while s(t) remained high in those with poor surgical outcomes.
Synchronizability curves for other frequency bands can be found in Supplementary Figure
3.1.

Figure 3.3. Time-varying network synchronizability is predictive of surgical
outcome. (A) Median base network synchronizability in good outcome patients (blue)
and poor outcome patients (red) for broadband intracranial EEG (IEEG), *** = p <
0.001. Shaded areas show 95% CIs. (B) Patients with lesional MRI have higher preictal synchronizability than non-lesional (NL) patients, * = p < 0.05. (lesional, pre-ictal:
min = 0.42, 25% ile = 0.55, median = 0.60, 75% ile = 0.67, max = 0.74. NL, pre-ictal:
min = 0.33, 25% ile = 0.59, median = 0.63, 75% ile = 0.67, max = 0.85. lesional, ictal:
min = 0.40, 25% ile = 0.51, median = 0.55, 75% ile = 0.61, max = 0.70. NL, ictal: min
= 0.40, 25% ile = 0.51, median = 0.56, 75% ile = 0.60, max = 0.74) (C) ROC curves
were constructed by calculating difference in s(t) from pre-ictal to ictal periods and
sweeping the threshold for classification. Broadband IEEG predicts surgical outcome
significantly better than other bands as assessed by the DeLong test which statistically
compares ROC curves generated from correlated data.
We also asked whether there is an association between synchronizability and
clinical variables used to guide therapy such as lesion status on MRI. We found that patients
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who were non-lesional (n = 14) had higher pre-ictal synchronizability in broadband
compared to patients with lesions (n = 11) (rank-sum statistic -1.984, p = 0.047) (Figure
3.3B), even though there was no correlation with lesion status and outcome (chi-square test
= 0.178, p = 0.67) or electrode number (rank-sum statistic 267, p = 0.79) in our study.
In order to quantify the ability of synchronizability to predict surgical outcome, we
calculated median change in s(t) from pre-ictal to ictal periods, and performed a sweep of
that feature to generate a receiver operating characteristic (ROC) curve (Figure 3.3C).
Despite the small sample size, the Ds(t) derived from broadband ECoG data (AUC=0.89,
95% CI 0.76-1.00) is predictive of surgical outcome. This ROC curve showed greater
statistical significance than that observed in each of the other frequency bands. Selecting
the point on the ROC which gave the greatest number of correct classifications, we choose
a threshold of Ds(t) = 0.0279 to determine the performance of our predictive model based
on broadband networks across all 28 patients in our cohort. We find an accuracy of 0.86
with a true positive rate of 0.88 and a true negative rate of 0.82 (Supplementary
Table 3.1).
3.4.2 Virtual resection provides novel clinical insight
We sought to determine whether the virtual resection model provides additional
information on patient prognosis that is not merely correlated with traditional
electrographic findings such as DC shift, clear seizure focus, and low voltage fast activity.
While a significant decrease in broadband synchronizability at seizure onset carries an odds
ratio of 35 for good surgical outcome, having a focal seizure onset zone, low voltage fast
activity, or a DC shift do not perform as well with odds ratios of 4.3, 1.5, and 7 respectively
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(Supplementary Table 3.2). We present the EEG and synchronizability of two patients that
our model predicted correctly (Figure 3.4). In these cases, following electrographic features
alone did not correlate with outcome and we find that virtual resection provides novel
clinical information not captured by traditional clinical analysis. We then asked the
following questions: How does control centrality cres(t) of the resection zone change before
and during a seizure? How does it differ between patients who fare favorably and patients
who fare poorly after surgery? We observed that median cres(t) was lower in good outcome
patients compared to poor outcome patients during the ictal period. In focal impaired
awareness seizures the b frequency analysis was strongest (rank-sum statistic –2.10, p =
0.036), while in focal to bilateral tonic-clonic seizures this effect was strongest in high-g
(rank-sum statistic –2.43, p = 0.015) (Figure 3.5). We note that after adjusting the alpha
level to 0.0083 for multiple comparisons, these results no longer reached statistical
significance. The effect was not significant during pre-ictal periods or in other frequency
bands (Supplementary Figure 3.2). Additionally, calculated cres(t) is robust to segmentation
error at the resection zone margin (Supplementary Figure 3.3). These findings align with
our initial hypotheses as well as with the theoretical understanding of the virtual resection
network analysis.

41

Figure 3.4. Synchronizability provides novel clinical information. (A) Our model
correctly predicted HUP073 to be seizure free after surgery. A board certified
epileptologist determined there is no DC shift, low voltage fast activity, or clearly focal
seizure onset. This stereotyped clinical seizure results in arousal from sleep without
evident EEG change. While the clinically marked seizure onset began with an arousal
pattern in LLT04-06, here rhythmic activity begins in ROF1-3 60 seconds into seizure,
later progressing to RLT1-3. .Resection was performed in the right frontal region.
Synchronizability decreases throughout the seizure in this patient, predicting seizure
freedom after surgery. (B) Our model correctly predicted the poor outcome of patient
HUP080. In the displayed seizure, a board certified epileptologist determined seizure
onset electrodes of AST1-3 with the presence of low voltage fast activity (red box), and
a clearly focal seizure onset but no DC shift. Synchronizability increases after EEC in
this patient, correctly predicting the surgical outcome of this patient to be poor. EEC =
earliest electrographic change.
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Figure 3.5. Control centrality of resection zone. Median node-level control centrality
-- calculated for the entire group of nodes lying within the resection zone -- are shown
for different seizure types. Good outcome patients have regions that play a greater
synchronizing role resected compared to poor outcome patients. This effect is greatest
in the b band for focal impaired awareness seizures (good: min = -0.044, 25% ile = 0.021, median = 0.017, 75% ile = 0.060, max = 0.220, poor: min = 0.046, 25% ile =
0.071, median = 0.088, 75% ile = 0.095, max = 0.183) and in the high-g band for focal
to bilateral tonic-clonic seizures (good: min = -0.050, 25%ile = -0.017, median = -0.006,
75% ile = 0.010, max = 0.034, poor: min = 0.019, 25% ile = 0.023, median = 0.042,
75% ile = 0.067, max = 0.090).
3.4.3 Virtual resection maps spatial anomalies in seizure networks
To examine the implications of virtual resection results on clinical management,
we sought to elucidate the role that various clinical features can play on virtual resection
features. We sought to study the spatial distribution of cres(t) in patients who had undergone
focal resections with malformations of cortical development (MCD), such as focal cortical
dysplasia. There were six patients with MCD of which two were read as MRI-normal. Five
of these patients had favorable outcome. Figure 3.6 shows patients with MCD on pathology
and their respective mean control centrality across pre-ictal and ictal epochs derived using
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the broadband cross-correlation metric for functional connectivity. In high frequency
bands, during pre-ictal periods, we observed that MCDs exhibit stronger synchronizers
perilesionally (pre-seizure: rank-sum statistic –2.08, p = 0.04). We also found strongly
desynchronizing nodes in the b band during ictal periods perilesionally within the resection
zone compared to non-lesional patients (seizure period: rank-sum statistic 1.71, p = 0.09).
However, neither of these results achieved statistical significance after correcting for
multiple comparisons. These closely localized desynchronizing nodes near lesions may be
important controllers that act on nearby seizure generating regions next to dysmorphic
dysplastic tissue. Since this finding was present even in the two non-lesional patients with
MCD, spatial maps of control centrality may act as a biomarker to uncover hidden
epileptogenic lesions that may not be easy to identify on standard clinical neuroimaging.

Figure 6. Control centrality uncovers malformations of cortical development.
Spatial maps of mean control centrality for each node are shown for all five patients:
three lesional and two non-lesional on MRI, seen above. All patients had pathologyconfirmed malformations of cortical development (yellow arrow). Two patients had
non-lesional findings on MRI despite presenting a spatial pattern of node-level control
centrality similar to those in other patients with MRI-positive MCDs. Specifically,
strong desynchronizing regions (red) are seen in all resected regions (darkened zone
with white outline) which contain MCDs (synchronizers, blue). Artifactual electrodes
not included in analyses are denoted with black dots.
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3.5 Discussion
In this study, we investigate the ability of virtual resection to accurately predict
surgical outcome using functional networks derived from ECoG data, expertly annotated
seizure markings, and rigorous coregistration of intracranial electrodes and resected brain
regions. We determine that decreased synchronizability at the time of seizure onset is
predictive of good outcome, performing better than traditional electrographic features. We
further suggest that good outcome patients have brain regions removed with a relatively
greater synchronizing effect on broader networks than those of poor outcome patients.
Finally, we propose that our robust pipeline incorporating rigorous clinical marking and
validation of ECoG, quantified resection zones on standardized MRI after surgery, and
sharing of all code and data are novel contributions that make this study important.
In our validation of the virtual resection method, we uncover relationships between
synchronizability and important clinical variables. Broadband synchronizability has a
significant decrease at seizure onset in good but not poor outcome patients, and pre-ictal
synchronizability is higher in non-lesional patients than those with a clear lesion on MRI.
The notion that good outcome patients have a decrease in synchronizability at seizure onset
is intriguing because it suggests a greater resistance to the propagation of oscillatory
epileptic activity throughout the network early in seizures. For patients without this
decrease in synchronizability, traditional resections may not provide a cure as the existing
epileptic network may poorly constrain abnormal activity. Furthermore, heightened preictal synchronizability in non-lesional patients could underlie differences in the
pathophysiology of seizure generation. Furthermore, the robustness of our methods to
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predict both non-lesional and lesional patient outcomes equally well is exciting and a clear
strength of this study as there is substantial literature supporting improved outcomes in
lesional epilepsy83,86. While our retrospective analysis is not designed to conclusively
prove the mechanism by which either of these observations occur, future experimental
studies may explore these concepts in vivo. As we continue to extend virtual resection and
provide support of its utility we further aim to initiate a prospective clinical trial in the
future.
We used differences in synchronizability between good and poor outcome patients
to predict surgical outcome and show that it provides novel information not present in
traditional electrographic features. Using the change in median s(t) from the pre-ictal to the
ictal period, we predict surgical outcome with accuracies that compare favorably to other
recently-published in silico models of resective epilepsy surgery65,66,80,93. We also show
that examining synchronizability curves can uncover novel information about the epileptic
network that is often not present in traditional electrographic localizing features of focal
SOZ, DC shift, and LVFA. These findings support the use of our model as an adjunct to
traditional EEG interpretation and may identify patients for whom surgery could eliminate
their seizures as well as those unlikely to benefit from intervention. We envision clinicians
interacting with our model in a similar approach to Figure 3.4, where synchronizability,
control centrality, and EEG are viewed alongside each other. A holistic assessment of the
full clinical information such as electrographic features is always warranted, however our
findings support the use of synchronizability to support surgical decision-making.
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Examining the contribution of the resection zone to overall network dynamics may
be a powerful tool for assessing surgical intervention. While the results of this analysis are
not statistically significant after adjusting for multiple comparisons, median control
centrality of the resection zone is lower in good outcome patients (Supplementary Figure
3.2) across all frequency bands which are correlated. We observe that good outcome
patients may be more likely to have lower control centrality of their resection zones,
meaning that the resected tissue plays more of a synchronizing role in the overall network.
It follows that such patients would have good outcome as the topology of the resulting
functional brain network would have decreased synchronizability. Performing a high
resolution spatial mapping of individual synchronizing and desynchronizing nodes such as
in Figure 3.6 may also provide insights into these concepts in the context of specific
pathologies. However, larger collaborative datasets are needed to robustly uncover disease
specific patterns as our results do not reach statistical significance after adjusting for
multiple comparisons. It is tempting to infer that our finding suggests that these regions
function as a macro-scale “inhibitory surround,” analogous to that seen in more controlled
studies of seizure propagation in animal models and humans45, but this hypothesis would
require further investigation.
Broadband cross-correlation may have higher predictive power compared to
individual frequency bands because it provides the most general assessment of network
connectivity without frequency-specific information. Given that broadband has high
correlation with all other frequency bands (Supplementary Figure 3.4), broadband may be
the most generalizable as it would not be as affected by differences in individual seizure
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pathophysiology. Furthermore, previous network models of epilepsy have found
broadband to be highly predictive93. On the other hand, when examining control centrality
of the resection zone parsed by seizure types we find frequency differences that are not
apparent in the broadband analysis. The finding that high-g synchronization was most
associated with good outcome in focal seizures that generalized whereas b synchronization
was associated with good outcome in focal seizures that did not spread may be rooted in
different mechanisms underlying these events.
Recent work has attempted to study the spatiotemporal dynamics of seizures from
initiation to termination4,94. Onset patterns are not determined by initiation of aberrant
activity in the seizure onset zone core alone, but additionally by how changes in excitability
in surrounding healthy tissue cause the onset to become evident95. These network state
changes may serve as control mechanisms enabling desynchronous activity to disrupt
seizures or to coalesce tightly bound and functionally cohesive network components47. As
a result, some nodes may be seizure desynchronizers that should potentially be left intact
in any resection plan (Figure 3.7). In Figure 3.7, the proposed resection zone is the group
of synchronizing nodes that fell within the original resection zone, while nodes marked to
avoid are desynchronizing nodes that were resected. The predictions of our model need to
be validated in a prospective trial before translating them into patient care. Additionally,
other nodes may act as strong synchronizers during seizure evolution and perhaps could be
especially targeted for ablation, resection or stimulation. Studying these findings broadly
across connected brain regions could identify potential targets for focal therapy outside of
the seizure onset.
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Figure 3.7. Proposed framework for optimal resection targets using virtual
resection. Median node-level control centralities during interictal, pre-ictal and ictal
periods are shown for a sample patient who had poor outcome. The top row shows
spatial maps with the resection zone (darkened region with white outline) and the
bottom row shows regions that perhaps should be targeted for resection due to the
presence of strong synchronizing nodes (blue), or should be avoided during resection
due to the presence of strong desynchronizing nodes (red). Future experiments assessing
the effects of stimulation of these nodes and subsequent changes in synchronizability
will allow clinicians to better predict the effect of targeted resection of these nodes.
The virtual resection method allows for mapping of control mechanisms of epileptic
networks outside of seizures as well. The model can be extended to interictal periods
without the need for ictal markings because repetitive, stable topographical patterns in
functional connectivity emerge across long interictal time periods. Additionally, subgraphs
identified in interictal periods are similar topologically to those identified during seizures59,
allowing for generalization of the virtual resection method to interictal epochs. Interictal
epileptiform discharges may also be incorporated into the virtual resection framework by
studying the regions that generate spikes in terms of their interictal, pre-ictal and ictal
control centrality. The flexibility of our methods to various modes of analysis is a clear
strength of our study.
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The natural next step in testing the idea that resection should target synchronizers
and preserve desynchronizers is to relate the effects of local stimulation to regional control
centrality. Brain stimulation performed either intraoperatively or in the epilepsy
monitoring unit may provide a safe and effective way to experimentally test network
hypotheses by determining whether activation of certain nodes results in the generation or
interruption of epileptic activity. Relating stimulation to virtual resection measures may be
useful to fully describe spatiotemporal dynamics and would provide an avenue to formulate
an algorithm to target resection. As recent technology allows intracranial EEG streaming
to online cloud platforms96 our virtual resection method and calculation of network metrics
could also be implemented in real time during stimulus-based mapping. If successful, these
methods could be extended to guide therapy with closed-loop neurostimulation devices
such as the Neuropace RNS.
The methods and results of our model are derived from patient-specific ECoG and
imaging data and compare favorably with previous studies of in silico models of resective
epilepsy surgery. In particular, studies have often performed the identification of ictogenic
nodes whose resection influences outcome by using neural mass models parameterized by
functional connectivity. First, Sinha et al. (2017)65 identified nodes that caused the network
to transition the fastest into seizure dynamics via a subcritical Hopf bifurcation97. Second,
Goodfellow et al. (2016)66 used a more mechanistic model that identified nodes where
removal would reduce epileptiform dynamics via saddle-nodes on a limit cycle bifurcation.
In contrast, our current virtual resection study uses a network framework to directly
describe the node level and global dynamics of each patient’s seizures as they occur. Our
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approach is thus not constrained by simulated seizures whose dynamics may be at odds
with those observed in clinical data, and instead allows clinicians to assess intracranial
EEG network properties derived from the very same data on which they currently base
clinical decisions. Furthermore, our quantitative imaging pipeline and high quality dataset
is larger than either of the previous studies, which bolsters the generalizability of our
results. We also use data from each seizure and a corresponding preictal period for each
patient in our study rather than just the first seizure or purely interictal data. Each of these
advantages of our study brings us closer to a clinical tool and demonstrates the significant
novelty of our work in the field of personalized network models of epilepsy.
Our study has several important limitations. The small number of patients tested
decreases the statistical power of this study, and before the technique can be applied
clinically, it must be tested on a broader range of epilepsy types. It also must be validated
on stereotactic EEG recordings which are rapidly becoming the standard for many epilepsy
centers worldwide as they use depth electrodes to sample broader brain networks yet
require a less invasive implantation procedure. Another limitation of our network
neuroscience approach is the sensor-level brain regions that we call ‘nodes’ are neither
spatially discrete nor fixed in their locations across patients as intracranial electrodes are
not implanted with connectivity studies in mind. One limitation of all studies using
functional connectivity derived from ECoG is the sampling bias introduced by electrode
placement, which may impact the reliability of summary statistics derived from network
models. We have found that even upon 20-40% resampling of electrodes, network metrics
including control centrality and synchronizability are reliable and perform in line with
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other metrics used in the field71. Furthermore, statistical methods such as jackknife
resampling can be used to determine relative spatial confidence in network model results71.
Unfortunately, we cannot validate whether the predictions regarding changes in
synchronizability after resection result in an altered epileptic network that is less likely to
manifest seizures. Direct brain recordings post-surgery would be an ideal method of model
validation but these are not performed as part of clinical care at our institution.
A further nuance of our study is that all seizures were considered and analyzed for
every patient. Patients undergoing electrode implantation and monitoring are frequently
observed to have aberrant seizures and discharges attributed to electrode trauma as well as
events occurring in regions that do not give rise to the patient’s stereotyped clinical
events3,98,99. The true causes of these seizures and their significance is unknown.
Additionally, in our synchronizability analysis we average all seizures within a patient,
even for mixtures of focal impaired awareness and bilateral tonic-clonic seizures. This
approach diminishes sensitivity in detecting dynamic changes associated with different
seizure subtypes. However, we feel that “human filtering” of data by selecting subtypes
would add bias to our results and add a level of subjectivity to our methods that would
make them quite difficult to translate to clinical practice, particularly at different medical
centers using slightly different ECoG interpretation criteria. While this attests to the
generalizability of the method, we need to further refine spatiotemporal mapping.
We present a method for rigorously mapping epileptic networks and predicting
outcome based upon rigorously validated resection of network nodes. In spite of study
limitations, our results suggest that these tools may have value in planning epilepsy
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surgeries, identifying patients in advance who are likely to have good outcomes, and also
those who are less likely to benefit from surgical resection. We hope that this work may be
a step in further standardizing invasive epilepsy procedures and treatment, and initiating
multi-center clinical trials that reduce individual variation from center to center in this vital
part of patient care.
3.6 Supplemental materials

Supplemental Figure 3.1. Pre-resection synchronizability curves for all frequency
bands. The above figure shows the time-varying distribution of s(t) during pre-ictal and
ictal periods across different outcome groups and frequency bands after timenormalization to 10 time bins. Immediately following seizure onset, mean network
synchronizability decreased in both outcome groups, with greater decrease in good
outcome patients. With the use of functional curve analysis (10,000 permutations), all
ictal events were significantly different (p < 0.001) in shape and time evolution.

Supplementary Figure 3.2. HUP073 ictal pattern 60 seconds after EEC.
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Supplementary Figure 3.3. Resection zone control centrality for all frequency
bands. Patients with good surgical outcome have resection zones with lower control
centrality, implying that tissue with greater synchronizing properties was resected. * =
p < 0.05.

Supplementary Figure 3.4. Outcome prediction is robust to error in resection zone
mapping. AUC of ROC curves are shown as a function of resection volume measured
by percentage of network nodes removed. Segmentations were both dilated and eroded
up to 20% of the network and resulting network measures were used to predict outcome.
The numbers in parenthesis indicate the number of patients that still had electrodes left
after erosion. AUC values remained high despite variance up to 10% in resected nodes.
These results suggest fewer electrodes can be targeted for resection and potentially
augur favorable outcome.
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Supplementary Figure 3.5. Correlation of functional connectivity between
frequency bands. Similarity values were generated by measuring Pearson correlation
between edges in the functional connectivity matrix. The Pearson correlation coefficient
values were averaged across time, seizures and patients. We considered the pre-ictal
and ictal periods separately. We observe moderate correlations across frequency bands
(r = 0.24 – 0.67) overall, with broadband networks more correlated to frequency specific
bands than frequency specific bands to each other. Frequency specific bands were more
highly correlated to adjacent frequency bands than bands much different in frequency.
Average correlation across frequency bands in the ictal period was higher than in the
pre-ictal period.

Feature OR (95% CI) p value
Δs(t) 32 (3.2-271)
0.00005
LVFA 1.5 (0.3-7.2)
0.71
Focal SOZ 4.3 (0.6-29)
0.17
DC shift 7 (0.7-68)
0.098
Supplementary Table 3.1. Odds ratios for associations with good surgical outcome.
A board certified epileptologist determined the presence of low voltage fast activity,
clearly focal SOZ and DC shift in all patients in our study, and we compared the odds
ratio of the presence of each of these localizing EEG features with that of having a
decrease in broadband synchronizability at seizure onset. P values determined by twotailed Fisher exact test.
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PREDICTED
OUTCOME

N = 28
Good
Poor
Accuracy =
0.86

SURGICAL
OUTCOME
Good
TP = 15

Poor
FP = 2

FN = 2
TPR = 0.88

TN = 9
TNR = 0.82

Supplementary Table 3.2. Confusion matrix for virtual resection predictions. TP
= true positives, FP = false positives, FN = false negatives, TN = true negatives, TPR
= true positive rate, FPR = false positive rate.
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CHAPTER 4: The effects of sampling bias on network models
4.1 Abstract
Focal epilepsy is a clinical condition arising from disordered brain networks.
Network models hold promise to map these networks, localize seizure generators, and
inform targeted interventions to control seizures. However, incomplete sampling of
epileptic brain due to sparse placement of intracranial electrodes may profoundly affect
model results. In this study, we evaluate the robustness of several published network
measures applied to intracranial electrode recordings and propose an algorithm, using
network resampling, to determine confidence in model results. We retrospectively
evaluated intracranial EEG data from 28 patients who were implanted with grid, strip, and
depth electrodes during evaluation for epilepsy surgery. We recalculated global and local
network metrics after both randomly and systematically resampling subsets of intracranial
EEG electrode contacts. We found that sensitivity to incomplete sampling varied
significantly across network metrics, and that this sensitivity was independent of the
distance of removed contacts from the seizure onset zone. We present an algorithm, using
random resampling, to compute patient-specific confidence intervals for network
localizations on both global and nodal network statistics. Our findings highlight the
difference in robustness between commonly used network metrics and provide tools to
assess confidence in intracranial network localization. We present these techniques as an
important step toward assessing the accuracy of intracranial electrode implants and
translating personalized network models of seizures into rigorous, quantitative approaches
to invasive therapy.
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4.2 Introduction
Epilepsy is a significant cause of disability worldwide, particularly among the one
third of patients whose seizures cannot be controlled by medications10. While these patients
may benefit from surgery or implanted devices, many continue to experience seizures after
invasive therapies1,86,100. One reason for this persistence of seizure activity may be the
difficulty in localizing seizure-generating brain regions, the drivers of complex epileptic
brain dynamics.
Clinicians and scientists now agree that epilepsy is in part a disease of brain
networks47. Driven by clinical observations, scientists have applied formal models from
network theory to better understand seizure dynamics and target therapy49. In these models,
the brain is discretized into regions represented by network nodes, while network edges are
used to represent their structural or functional connectivity. Network theory applied to
epilepsy employs a wide variety of metrics to understand seizure generation and control,
including node strength101 , eigenvector centrality54, betweenness centrality53, clustering
coefficient102, and control centrality4,55, as well as global metrics including global
efficiency103 , synchronizability4, and transitivity104. Collectively, these network measures
have been used to predict neuronal firing as seizures begin and spread, track seizure
progression, identify the seizure onset zone, and predict surgical outcome53,54,65,105–107.
When using invasive sensors such as intracranial EEG (iEEG) to estimate
functional connectivity, sampling from the full brain is impossible, and the network
measures available for modeling depend on the location and number of electrodes
implanted. In fields outside of epilepsy, missing data are known to affect the results of
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network analyses108–111. The effect of missing data on network models and clinical care in
epilepsy has not been rigorously explored. While network models have potential to add
rigor to clinical decision-making, their application may be limited by uncertainty in
estimated network metrics and the unknown interaction between that uncertainty and
sparse brain sampling. In this study we seek to rigorously assess the extent to which
different network metrics are sensitive to intracranial electrode sampling. Our goal is not
to determine which, if any, network statistic correctly localizes the seizure onset zone or
predicts surgical outcome, as this important work is currently under way by several
groups55,65,112,113. Rather, our goal is to determine (a) whether and how incomplete spatial
sampling affects the practical utility of network statistics, and (b) how sensitivity to spatial
sampling can estimate patient-specific uncertainty in network model predictions. This
computational work is a vital first step to deploying network models as an adjunct to
clinical decision-making.
4.3 Materials and Methods
We use a high-quality dataset that has been included in multiple network studies in
epilepsy4,55 and is publicly available at www.IEEG.org. We randomly eliminate nodes
from functional networks to simulate the uncertainty consequent to variable sampling of
brain regions by iEEG and to determine the reliability of different network metrics within
and across patients. Based upon the assumption that the main drivers of epilepsy network
behavior might localize to an epileptogenic region, we ask to what extent electrode contacts
far away from the seizure onset zone impact the estimated values of various network
metrics, and whether subsampling that targets the seizure onset zone disproportionately
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affects network statistics compared with subsampling that spares the seizure onset zone.
We then randomly remove nodes by jackknife subsampling in order to derive patientspecific estimates of confidence in network statistics.
4.3.1 Patient Selection, Intracranial EEG Recording, and Electrode Localization
All patients gave written informed consent in accordance with the Institutional
Review Board of the Hospital of the University of Pennsylvania (HUP) and the Mayo
Clinic in Rochester. Furthermore, all patients consented to publishing their full-length
iEEG recordings on the public web portal IEEG.org70. This study was performed in
accordance with the Declaration of Helsinki.
A total of 28 patients with drug-resistant epilepsy underwent iEEG recording during
presurgical evaluation at HUP or the Mayo Clinic. Electrode configurations (Ad Tech
Medical Instruments, Racine, WI) consisted of linear cortical strips and two-dimensional
cortical grid arrays (2.3-mm diameter with 10-mm intercontact spacing), and linear depth
electrodes (1.1-mm diameter with 10-mm intercontact spacing). EEG signals were
recorded at a sampling frequency of 512 Hz at HUP and 500 Hz at Mayo Clinic. All
electrode and EEG recording systems were FDA approved and are commercially available.
Each patient underwent MPRAGE T1-weighted magnetic resonance imaging
(MRI) on a 3T Siemens Magnetom Trio scanner (Siemens, Erlangen, Germany) prior to
electrode implantation, and they also underwent spiral CT imaging (Siemens, Erlangen,
Germany) after electrode implantation. We cross-referenced the CT images with a surgical
cartoon map to localize electrode coordinates. To segment the resection zone, we registered
the preimplant MRI to postresection imaging and the postimplant CT using the Advanced
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Normalization Toolkit114 (ANTs). We utilized a random forest classifier with ITK-SNAP
to semiautomatically estimate the resection zone and identify electrodes overlying resected
cortex89.
Seizures were identified clinically and confirmed in a clinical case conference
discussion. Board-certified epileptologists then reviewed the seizures and identified
the earliest electrographic change82 (EEC) and the electrode contacts of seizure onset
(identified using the clinical standard for recognizing the electrode contact with the EEC)
for each seizure. We performed our primary analysis on the first seizure identified for each
patient. For patients with more than one seizure (N = 26), we also performed the analysis
on the second seizure to assess the sensitivity of our results to the choice of seizure. For
patients with three or more seizures (N = 23), we also performed the analysis on the
patient’s last seizure in order to evaluate more temporally distant seizures, given evidence
that temporally clustered seizures may have similar dynamics, and given the possibility
that earlier seizures may be atypical because of postimplantation effect115,116. One patient
(HUP111) had two separate electrode implantations, and we analyzed both implantations
separately.
4.3.2 Calculating Functional Networks
We examined 1-s time windows (sampled at 512 Hz at HUP and 500 Hz at Mayo
Clinic) at each of the following time periods: 10 s prior to the EEC, 5 s prior to the EEC,
at the EEC, 5 s after the EEC, and 10 s after the EEC. We chose 1-s time windows so as to
have sufficient data to perform coherence calculations and because of the validation of this
time window in prior publications4,55,117. To determine the sensitivity of our results to this
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choice, we repeated this analysis with time windows of 2 s. We performed our primary
analysis on the time period at the EEC given evidence for changes in network parameters
that occur at the EEC4,77. We then repeated the analysis for each other time window in
order to assess the sensitivity of our results to the choice of time period, and given the
evidence that both interictal networks and post-EEC networks localize the seizure onset
zone54,113.
A common average reference was applied to iEEG signals to remove common
sources of noise. Data were filtered using an elliptic bandpass filter with cutoff frequencies
of 5 Hz and 115 Hz, as well as a 60-Hz notch filter to remove power line noise. Signals
were pre-whitened using a continuous autoregressive model to account for slow dynamics
and to accentuate higher frequencies known to be involved in seizure dynamics. This also
enhanced local neural population dynamics in order to minimize the effect of signal
mixing77,118,119. For each 1-s window, we constructed functional networks in which iEEG
electrode contacts represented network nodes. Edges were weighted by multitaper
coherence, which estimates the correlation between two electrode contact signals in the
frequency domain and is frequently used to calculate functional networks in neuroscience
publications4,120. We calculated coherence in the high gamma frequency band (95–105 Hz),
which we chose because of its importance in seizure propagation and spread4. We also
repeated the analysis in beta (15–25 Hz) to assess the sensitivity of our results to the choice
of frequency band, and in acknowledgment of the fact that the beta frequency is also
thought to be important in epileptic networks121. This separation of the data resulted in an
adjacency matrix for each frequency band representing a network with undirected,
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weighted edges for each patient, where each row and each column represented an electrode
contact, and each matrix element represented the signal coherence between the two
contacts.
To determine the sensitivity of our results to the choice of network density, we also
performed weight-based thresholding in which we set matrix elements below a weight w to
0, where w was tuned for each patient to achieve a network density of 0.5 (in addition to
the unthresholded network).
4.3.3 Network Metrics
For each functional network, we calculated several global and nodal network
metrics, chosen because of their importance in graph theory and their use in recent epilepsy
publications as described above. The global metrics were synchronizability, global
efficiency, and transitivity. The nodal metrics were node strength, control centrality,
clustering coefficient, eigenvector centrality, and betweenness centrality. The methods for
calculating these metrics have been previously described, and we briefly summarize each
below. We specifically describe their calculations for an undirected, weighted network. We
calculated each using the Brain Connectivity Toolbox122, or using custom code for
synchronizability and control centrality4.
Global efficiency is a global measure that is thought to represent how easily
information travels throughout the network123. It is defined as
𝐸=
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where E is global efficiency, N is the number of nodes, and σij is the shortest weighted path
length between node i and node j, for example estimated using Dijkstra’s algorithm124. A
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high global efficiency is thought to reflect a greater ease of information transfer throughout
the network. Path lengths were weighted by the inverse of the values of the adjacency
matrix, to reflect the fact that information is thought to be transferred more readily along
stronger edges125.
Synchronizability is a global metric that quantifies the stability of the fully
synchronous network state6,126 and has been shown to predict seizure generalization4. It is
calculated by first computing the weighted Laplacian L = D − A as the difference between
the node strength matrix D and the adjacency matrix A. Synchronizability is then obtained
by the equation Sync =  λ2/λmax, where Sync is synchronizability, λ2 is the second smallest
eigenvalue of the Laplacian, and λmax is the largest eigenvalue. Greater synchronizability
reflects a smaller spread between eigenvalues, which suggests greater ease for a network
to synchronize its dynamics.
Transitivity is another global measure that represents the degree to which nodes in
a graph tend to cluster together127–129. It is defined as T = ∑τΔ/∑τ, where T is transitivity,
∑τΔ is the sum of the weights of closed triplets, and ∑τ is the sum of the weights of all
triplets. A triplet is defined as a set of three nodes connected by either two or three edges.
A closed triplet, more specifically, is a set of three nodes connected by three edges. Higher
transitivity implies that nodes tend to cluster together into exclusive groups.
Node strength represents the total strength of connections involving a particular
node130, and is defined as
𝑠- = ∑%
/2$ 𝐴-/ ,
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in which si is the strength of node i, Aij is the adjacency matrix element containing the edge
weight between node j and node i, and N is the number of nodes. A high node strength
implies that the total weight of its connected edges is large. Eigenvector centrality is a
similar nodal measure that weights individual node influence by the relative influence of
each of its connected nodes106. It is specifically defined as λ = Ax, where x is the vector
containing the eigenvector centrality of each node, A is the adjacency matrix, and λ is the
largest eigenvalue of the matrix (which results in nonnegative eigenvector centralities). A
high eigenvector centrality implies that a node is strongly connected to nodes that
themselves are highly connected.
Betweenness centrality is a nodal metric that is closely related to the global metric
global efficiency and measures the fraction of all shortest paths in the network that pass
through a given node131. It is defined as
𝑏- = ∑5.-./
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where bi is the betweenness centrality of node i, σhj(i) is the number of shortest paths from
node h to node j that pass through node i, and σhj is the total weighted path length between
node h and node j. A high betweenness centrality suggests that the node acts as a central
node in the shortest paths between many other nodes. The path lengths were weighted by
the inverse of the values of the adjacency matrix as described above.
Control centrality is a local metric that measures the effect of each node on
synchronizability. It is defined as
𝑐- =
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where ci is the control centrality of node i, Syncold is the original synchronizability,
and Syncnew is the synchronizability of the network with the node removed4. Negative
control centrality nodes are synchronizing, whereas positive control centrality nodes are
desynchronizing.
Clustering coefficient is the nodal extension of transitivity that measures the
amount of interaction between local triplets132. It is calculated by
𝑐𝑙- = 2 ∑I,/

(C+, CD, C+D )E/G
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in which A is the adjacency matrix edge weight and v is the number of neighbors. Higher
clustering coefficients reflect greater clustering of the node into tight groups.
4.3.4 Network Subsampling
To determine the sensitivity of network metrics to spatial sampling, we randomly
identified electrode contacts for removal in each patient. We removed the rows and
columns corresponding to these electrode contacts from the adjacency matrix representing
the network. We recalculated each of the network metrics above. We performed this
analysis removing 20%, 40%, 60%, and 80% of randomly selected electrode contacts. We
repeated this process 1,000 times for each removal percentage to obtain a distribution of
new metrics in the randomly subsampled network (Figure 4.1).
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Figure 4.1: Network generation and resampling methods. A: Seizure onset times
were marked by a board-certified epileptologist. Resected brain areas corresponding to
EEG channels were determined through a semi-automated imaging technique and
confirmed by a board-certified neuroradiologist. B: Multitaper coherence of a 1-second
interval of EEG signal at seizure onset was used to create a functional adjacency matrix.
C: Network metrics were calculated using the adjacency matrix with all nodes included.
D: A subset of nodes were removed to simulate the effect of leaving out electrodes. E:
Network metrics were recalculated from the resampled network. F: This process was
repeated over 1,000 iterations and the reliability of each metric was quantified.

4.3.5 Determining Metric Reliability
To determine the stability of each network metric to subsampling, we calculated
the reliability for each removal percentage133. Reliability is defined as
𝑅=

*LM

M
*N

,

where 𝜎PQ = 𝜎RQ + 𝜎SQ , 𝜎RQ is the variance of the true scores, 𝜎SQ is the variance of the error,
and 𝜎PQ is the total variance. We defined the variance of the error to be the variance of the
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subsampled metric across the 1,000 random subsamples, averaged across electrode
contacts in the case of nodal metrics. For nodal metrics, we defined the variance in the true
scores to be the variance of the subsampled metric across electrode contacts, averaged over
all permutations. In the case of global metrics, we defined the variance in the true scores
to be the variance in the subsampled metric across patients, averaged over all permutations.
Reliability is constrained to be between 0 and 1, where 1 indicates that no variance is due
to random subsampling, 0 indicates that all variance is due to random subsampling, and 0.5
indicates that the variance due to random subsampling equals the variance of the true
metric. The goal of the reliability measure is to compare how much metrics vary across
subsamples relative to how much they vary across patients (in the case of global metrics)
or electrode contacts within the patient (in the case of nodal metrics). Lower reliabilities
suggest that the variance across subsamples is higher than that across patients (global
metrics) or electrode contacts (nodal metrics), suggesting that minor changes in electrode
configurations could result in different orderings of highest-to-lowest metric values, thus
decreasing our confidence in the result. Of note, we calculated the variance in the true
scores in the subsampled networks, rather than the original network, to avoid a bias in
which some network metrics (such as node strength) have larger values and larger
variances

across

electrodes

in

larger

networks,

resulting

in

paradoxically higher reliabilities when removing more electrodes.
To determine whether some metrics were more robust to subsampling than others,
we compared the metric reliability across all patients for the 20% removal percentage using
separate Friedman tests, one for global metrics and one for nodal metrics134 (α = 0.05). In
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the case of significant Friedman test results, we performed post hoc Dunn-Šidák multiple
comparisons tests to identify significant differences between individual metrics135,136. We
also determined the reliability of metrics for removal percentages other than 20%, which
we report in our Supporting Information. We repeated this analysis for beta band
coherence, alternate times relative to the EEC, removal of contiguous rather than random
electrode contacts, alternate network densities, alternate time windows for calculating
coherence, and different seizures, which we also report in our Supporting Information.
As an additional test of network stability to subsampling for nodal metrics, we
calculated the Spearman rank correlation of the vector of nodal metrics across electrodes
between the original network and each of the 1,000 subsampled metrics. We obtained the
mean of the rank correlation across all 1,000 subsamples as a measure of the average
correlation between the original set of nodal metrics and the subsampled metrics. We
compared the metric rank correlations across all patients for the 20% removal percentage
using a Friedman test (α = 0.05), performing post hoc Dunn-Šidák multiple comparisons
tests to identify significant differences between individual metrics in the case of significant
Friedman test results.
We then determined whether there was a relationship between the network
reliability and the number of electrode contacts comprising the original network. We
obtained the reliability for each patient and each nodal and global metric at the 20%
removal percentage of random electrode contacts, using the EEC time period and gamma
band coherence. For each metric, we correlated the reliability with the original number of
electrode contacts in the patient’s network using Spearman rank correlation. We performed
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Bonferroni correction as we were testing eight network metrics, yielding an α of 0.05/8 =
0.00625.
4.3.6 Influence of Seizure Onset Zone on Network Reliability
We next hypothesized that ictal network metrics may be more affected by removing
electrode contacts near the seizure onset zone, as these contacts may have a stronger
influence on epileptic networks. To test this, we again subsampled the network, this time
systematically removing each electrode contact and its N − 1 nearest neighbors,
where N was equal to 20% of the total number of contacts in the network (we also
calculated it for other removal percentages and report these results in our Supporting
Information). We recalculated each of the global and nodal metrics in this systematically
subsampled network. We obtained a measure of agreement between the original metric and
the new metric in the subsampled network. For nodal metrics, the agreement measure a
was defined as the Spearman’s rank correlation coefficient across electrode contacts
between the original and subsampled metric. For global metrics, the agreement measure
was defined as the negative of the absolute value of the relative difference between the two
metrics, represented by the equation
WXYZ-:;<= 'WXYZ-:>?@
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The global agreement a was equal to 0 when there was perfect agreement between the new
and original metric, and was increasingly negative with larger absolute differences.
To test whether there was larger metric agreement when the removed electrode
contacts were further from the seizure onset zone, we obtained the Spearman’s rank
correlation coefficient between the agreement measure a with the distance between the
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centroid of the removed electrode contacts and the centroid of the seizure onset zone. We
obtained the Fisher’s transformation of the rank coefficient for each patient, which is equal
to the inverse hyperbolic tangent of the rank coefficient, in order to transform the
coefficients to a variable whose distribution is approximately normal137. We aggregated
these transformed rank coefficients across patients and performed a two-sided onesample t test to determine whether the mean coefficient was significantly different from 0.
We performed this test for each of the global and nodal metrics. We performed Bonferroni
correction as we were testing eight network metrics, yielding an α of 0.05/8 = 0.00625.
As an additional test of the hypothesis that removing seizure onset zone electrodes
disproportionately affects network statistics, we performed two additional subsampling
methods: a seizure onset zone-targeted subsampling and a seizure onset zone-sparing
subsampling. In the seizure onset zone-targeted subsampling, we identified all electrodes
forming the clinician-defined seizure onset zone and we removed all of these and only
these electrodes. In the seizure onset zone-sparing subsampling, we identified a randomly
selected subset of electrodes, equal in number to the number of seizure onset zone
electrodes, but excluding the seizure onset zone (in one patient, Study022, the number of
seizure onset electrodes was more than half of the total number of electrodes, and in this
case we removed all other electrodes for the seizure onset zone-sparing subsampling). We
repeated the seizure onset zone-sparing subsampling 1,000 times. For each subsampling,
we again calculated the agreement, a, between the original and subsampled network
statistics, where a is defined above for both global and nodal metrics. We took the mean
agreement across all 1,000 subsamples in the case of seizure onset zone-sparing
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subsampling. We compared the mean seizure onset zone-sparing agreement and the seizure
onset zone-targeted agreement with a two-sided paired t test to determine whether the
metric agreement when subsampling using a seizure onset zone-sparing method was
significantly different from that using a seizure onset zone-targeted method. We performed
this test for each of the global and nodal metrics. We performed Bonferroni correction as
we tested eight network metrics, yielding an α of 0.05/8 = 0.00625.
As an alternative approach, we also calculated for each patient the percentage of
seizure onset zone-sparing agreements that were higher than the seizure onset zonetargeted agreement. We performed a one-sample two-sided t test to determine whether the
mean percentile was significantly different from 50% (under the null hypothesis that if the
seizure onset zone contacts were not of particular importance to the network metrics, half
of patients would be expected to have higher seizure onset zone-sparing versus seizure
onset zone-targeting agreements), using a Bonferroni correction for eight network metrics
(α = 0.00625). Of note, there were six patients for whom the number of seizure onset zone
electrode contacts was large relative to the total number of electrode contacts (approaching
half), and so for these patients there was likely a high interdependence between the 1,000
seizure onset zone-sparing subsamples. We expect that this makes this analysis less
conservative than our primary analysis above.
We repeated the seizure onset zone analyses restricting analysis to patients with
good (International League Against Epilepsy, ILAE = 1) outcomes (N = 13 patients), as it
is possible that in the poor-outcome patients, the clinician-defined seizure onset zone did
not accurately capture seizure generators. We also repeated these analyses using the
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electrodes overlying the resected area of cortex, rather than the seizure onset zone, while
restricting analysis to ILAE 1 outcome patients, under the assumption that the resected
cortex in these good-outcome patients likely overlaps with seizure generators.
4.3.7 Deriving Patient-Specific Confidence in Network Results Using Jackknife
Subsampling
We next utilized a jackknife subsampling method to generate patient-specific estimates in
the confidence of the results of network analyses. Jackknife estimation is a method of
sampling without replacement to derive statistical estimates138–140. It applies the same
subsampling technique from our earlier analyses, but with the aim of obtaining patientspecific confidence rather than metric-specific reliabilities. Our goal was to determine how
much a network result would be expected to change if a small number of electrode contacts
had not been present. We randomly removed 20% of electrode contacts, recalculated the
network statistic of interest for the random subsample, and repeated this process for 1,000
iterations. We chose a 20% removal percentage for this analysis to simulate minor
variability in electrode implantation strategy. For each of the nodal metrics, we identified
the electrode contact with the maximal metric value (minimal value for control centrality)
in each of the 1,000 iterations. We identified the electrode contacts comprising 95% of all
occurrences of the maximal metric value across the 1,000 iterations. We called this set of
contacts the 95% jackknife confidence contact set. We also identified the 95% confidence
contact set of the minimum regional control centrality, defined as the locations of an
electrode contact and its N − 1 nearest neighbors, where N equals the number of resected
electrode contacts that produces the largest negative change in synchronizability when
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removed. Regional control centrality attempts to identify a region of a defined size—rather
than a single electrode contact—with the largest control centrality, and thus a potential site
for resection55. A larger 95% jackknife confidence set of electrode contacts implies greater
sensitivity of the identity of the electrode contact with the maximal metric value to spatial
subsampling, suggesting lower confidence in the patient-specific network result. For global
metrics, we performed this method to obtain the 95% jackknife confidence interval for the
value of the metric for a given patient, which was the interval containing 95% of all values
obtained with jackknife subsampling. A larger 95% jackknife confidence interval for
global metrics implies greater sensitivity of the global network statistic to spatial
subsampling, suggesting lower confidence in the global network value. The runtime for the
jackknife subsampling algorithm (1,000 iterations) for all metrics at a single time and
frequency band was approximately ten minutes per patient when performed in MATLAB
R2018a on an Intel Xeon processor (CPU E5-2698 v3 @ 2.30 GHz).
4.3.8 Statistical Analysis
All analyses were performed on MATLAB R2018a (MathWorks, Natick). Specific
analyses are discussed in the four preceding sections, above.
4.4 Results
4.4.1 Patient and Electrode Information
Patients had a variety of clinical histories, electrode configurations, pathologies, and
clinical outcomes (Supplemental Table 4.1). There were 28 patients (13 women), one of
whom had two temporally distinct implantations, which were separately analyzed. The
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average age at implantation was 33.9 years (range 5–57). The mean number of electrode
contacts was 77 (range 16–118). The mean number of seizures was 6.8 (range 1–36). The
median ILAE outcome score at 2 years was 2 (range 1–5).
4.4.2 Stability of Metrics to Random Subsampling
For all network measures, reliability to subsampling decreased as more electrode
contacts were removed. The stability of network measures to subsampling varied across
patients (Figure 4.2). The mean reliability was R = 0.92 for synchronizability, R = 0.98 for
global efficiency, and R = 0.98 for transitivity, averaged over all patients when a random
sample of 20% of electrode contacts was removed. In contrast, when a contiguous sample
of 20% of electrode contacts was removed, the mean reliabilities were lower, with R = 0.85
for synchronizability, R = 0.92 for global efficiency, and R = 0.93 for transitivity. The
reliability to random electrode contact removal was significantly different between global
metrics (Friedman test: χ2 = 36.5, p < 0.001). Synchronizability was significantly less
reliable than either global efficiency or transitivity (post hoc Dunn-Šidák multiple
comparison test: t = −3.02, p = 0.008 compared with global efficiency and t = −6.04, p <
0.001 compared with transitivity). Global efficiency was also significantly less reliable
than transitivity (t = −3.02, p = 0.008). The reliability for global efficiency was slightly
lower than that for transitivity for 26 out of 29 patient implantations. However, for two
implantations the reliability for global efficiency was substantially larger, explaining why
global efficiency and transitivity have similar means despite global efficiency having
significantly lower reliability by ordinal statistics.
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When we examined the time periods 10 s before, 5 s before, 5 s after, and 10 s after
the EEC (as opposed to the second at the EEC), synchronizability continued to have the
lowest reliability of the global metrics. Control centrality continued to have the lowest
reliability of the nodal metrics, and eigenvector centrality and node strength continued to
have the highest reliabilities. The pattern remained when we examined beta frequency
coherence rather than high gamma frequency coherence, when we removed contiguous as
opposed to random sets of electrode contacts, when we examined the second seizure or the
last seizure rather than the first seizure, when we thresholded the network weights to
achieve a network density of 0.5, and when we used a 2-s time window for coherence
calculations rather than a 1-s window (Supplemental Table 4.2). When we instead removed
40% or 60% of electrode contacts, control centrality and synchronizability continued to
have the lowest reliability of nodal and global metrics, respectively, and node strength and
eigenvector centrality continued to have the highest nodal metric reliabilities. When we
removed 80% of electrode contacts, clustering coefficient instead demonstrated the lowest
nodal metric reliability, and otherwise the pattern was unchanged (Supplemental Table 3).
For nodal metrics, the Spearman rank correlation between the original and
subsampled met ric revealed the same ranking of metric robustness as with our primary
approach. The mean Spearman rank correlation between the original metric and the
subsampled metric, averaged across all subsamplings and all patients when 20% of
electrode contacts were randomly removed, was ρ = 0.84 ± 0.08 for control centrality, ρ =
0.97 ± 0.02 for node strength, ρ = 0.91 ± 0.03 for betweenness centrality, ρ = 0.98 ± 0.02
for eigenvector centrality, and ρ = 0.97 ± 0.02 for clustering coefficient. The Spearman
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rank correlation significantly differed across nodal metrics (Friedman test: χ2 = 99.5, p <
0.001). The Spearman rank correlation between the original and subsampled control
centrality metric was significantly lower than that for node strength (post hoc Dunn-Šidák
test: t = −5.81, p < 0.001), eigenvector centrality (t = −8.64, p < 0.001), and clustering
coefficient (t = −5.98, p < 0.001). The Spearman rank correlation between the original and
subsampled node strength metric was significantly higher than that for betweenness
centrality (t = 4.24, p < 0.001) and significantly lower than that for eigenvector centrality
(t = −2.82, p = 0.046). The Spearman rank correlation between the original and subsampled
betweenness centrality metric was significantly lower than that for eigenvector centrality
(t = −7.06, p < 0.001) and for clustering coefficient (t = −4.40, p < 0.001). The
comparisons between control centrality and betweenness centrality (t = −1.58, p = −0.704),
node strength and clustering coefficient (t = −0.17, p = 1.00), and eigenvector centrality
and clustering coefficient (t = 2.66, p = 0.076) were not significant.
We next examined the relationship between robustness to electrode contact
subsampling and the number of electrode contacts in the original network. Among global
measures, there was a significant positive relationship between reliability and number of
contacts for synchronizability (Spearman rank correlation: r27 = 0.68, p < 0.001), but not
for global efficiency (r27 = 0.20, p = 0.299) or transitivity (r27 = 0.22, p = 0.260). Among
nodal measures, clustering coefficient (r27 = 0.53, p = 0.003) demonstrated a significant
positive relationship, and relationships for control centrality (r27 = −0.12, p = 0.551), node
strength (r27 = 0.45, p = 0.015), betweenness centrality (r27 = 0.38, p = 0.043), and
eigenvector centrality (r27 = 0.44, p = 0.016) were nonsignificant (α = 0.00625, Bonferroni
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correction for eight measures). This pattern of findings suggests that, at least for
synchronizability and clustering coefficient, patients with more electrode contacts
implanted were less vulnerable to incomplete spatial sampling.

Figure 4.2. Reliability of network metrics to incomplete sampling. A: Reliability of
nodal measures, averaged across all patients, when different percentages of electrodes
were removed. B: Reliability of global measures, averaged across all patients, when
different percentages of electrodes were removed. Error bars show the standard
deviation of the reliability across patients. All data shown is for the EEC of first seizure,
high gamma coherence, and random electrode removal. For all measures, reliability
decreased as more electrodes were removed. Patients are heterogeneous in the reliability
of their network measures, and certain network measures exhibit higher reliability than
others.

4.4.3 Influence of Seizure Onset Zone on Sensitivity of Network Statistics to Subsampling
There was no significant association between metric agreement and distance of the
removed electrode contacts from the seizure onset zone for any metric (one-sample twosided t test: control centrality, t = 0.80, p = 0.433; node strength, t = 1.25, p = 0.222;
betweenness centrality, t = −0.95, p = 0.352; eigenvector centrality, t = 1.02, p = 0.318;
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clustering coefficient, t = 1.23, p = 0.230; synchronizability, t = −0.26, p = 0.793; global
efficiency, t = 0.74, p = 0.469; transitivity, t = 0.37, p = 0.717). This pattern of findings
implies that all metrics are equally sensitive to removing electrode contacts near versus
distant from the seizure onset zone (Figure 4.3). This result was invariant to the choice of
peri-ictal time window, choice of frequency band, choice of seizure, exclusion of nonILAE 1 outcome patients, use of resection zone rather than seizure onset zone (excluding
non-ILAE 1 patients), choice of network density, and choice of time window
(Supplemental Table 4.4) as well as to the choice of removal percentage (Supplemental
Table 4.5).

Figure 4.3. Association between metric agreement and distance of ignored
electrodes from the seizure onset zone. Each nodal and global metric is shown. Each
point represents the patient-specific Spearman rank correlation coefficient between the
metric agreement and the distance of the ignored electrodes from the seizure onset zone.
The metric agreement is defined for nodal metrics as the Spearman rank correlation
coefficient between the original metric and the metric obtained from resampling, and
for global metrics as the negative absolute value of the relative difference between the
original and resampled metric. Horizontal lines show the average distance-agreement
association across patients. No distance-agreement association was significantly
different from zero (two-sided one-sample t-test, α = 0.05/8. Bonferroni correction),
signifying that all metrics are equally vulnerable to incomplete sampling near versus
distant from the seizure onset zone.
When we compare metric agreement removing all seizure onset zone electrode
contacts as opposed to removing only non-seizure onset zone electrode contacts, there was
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again no significant difference in metric agreement between the seizure onset zone-sparing
and seizure onset zone-targeted approach for any metric (paired two-sided t test: control
centrality t = −0.99, p = 0.331; node strength, t = 0.84, p = 0.408; betweenness
centrality, t = 1.43, p = 0.167; eigenvector centrality, t = 0.81, p = 0.424; clustering
coefficient, t = 1.10, p = 0.283; synchronizability, t = 2.33, p = 0.028; global efficiency, t =
1.74, p = 0.095; transitivity, t = 2.65, p = 0.014; α = 0.00625, Bonferonni correction for
eight metrics). These findings suggest that sparing versus targeting seizure onset zone
electrode contacts for removal has equivalent effects on most network statistics. Across
conditions, transitivity generally displayed the largest differences between seizure onset
zone-sparing agreement and seizure onset zone-targeted agreement, although these
differences were significant only for the EEC + 10-s condition, the second seizure, and
50% network density (Supplemental Table 4.6). To determine whether the trend in
transitivity perturbation was to increase or decrease network transitivity, we obtained the
signed relative difference (as opposed to the metric ageement, which is unsigned) between
the subsampled and the original transitivity measure, and compared this for the seizure
onset zone-sparing and seizure onset zone-targeted subsampling methods. The relative
difference in transitivity was nonsignificantly higher (more positive) when seizure onset
zone-targeted subsampling was performed, which persisted across all time periods,
frequency bands, and the second seizure (Supplemental Table 4.6, two-sided paired t test,
α = 0.00625, Bonferonni correction for eight metrics). This suggests that removing seizure
onset zone electrode contacts may disproportionately increase transitivity (although this
result was nonsignificant for most conditions).
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When we used the approach calculating the percentage of seizure onset zone-sparing
agreements larger than the seizure onset zone-targeted agreement, we found that the seizure
onset zone-sparing agreement was significantly higher than the seizure onset zone-targeted
agreement for both synchronizability (one sample two-sided t test, t = 3.72, p = 0.001) and
transitivity (t = 3.04, p = 0.005) with no significant difference for other measures
(Supplemental Table 4.6). The directions of these results were the same as those seen in
the above analysis. However, given the dependence between seizure onset zone-sparing
subsamples discussed in the methods section, we believe that this analysis is less
conservative than our primary analysis above.
4.4.4 Jackknife Confidence Intervals
Both nodal and global metrics varied across patients with respect to jackknife
confidence intervals produced by subsampling (Figure 4A–C). The median and range for
the number of electrode contacts accounting for 95% of all jackknife instances of the
maximum nodal metric (minimum for control centrality) was 3 (range 2–5) for node
strength, 4 (3–9) for betweenness centrality, 3 (2–5) for eigenvector centrality, 3 (2–5) for
clustering coefficient, and 9 (4–22) for control centrality. The median number of electrode
contacts accounting for 95% of all jackknife instances of the minimum regional control
centrality (where the set of electrode contacts with minimum regional control centrality is
the set, equal in number to the number of resected electrode contacts, that together produces
the largest negative change in synchronizability when removed) was 48 (range 12–93). The
median ratio between this number and the number of electrode contacts forming the true
minimum regional control centrality set was 4.0 (range 1.6–16.0; Figure 4.4D). Regarding
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global metrics, the median width of the 95% jackknife confidence interval was 0.094 (range
0.045–0.192) for synchronizability, 0.016 (range 0.006–0.058) for global efficiency, and
0.012 (range 0.004–0.062) for transitivity (Figure 4.4E). These results demonstrate the
heterogeneity among patients in the level of confidence in estimated network statistics that
can be revealed by the jackknife algorithm. The locations of electrode contacts with the
maximum or minimum metric values, as well as the results of jackknife subsampling,
varied somewhat across time periods, choice of frequency band for coherence, seizure,
network density, and time window for coherence calculations (Supplemental Figure
4.1, Supplemental Table 4.7).
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Figure 4.4. Jackknife resampling to estimate confidence regarding network metric
values. A: The location of the electrode with the highest node strength, as well as the
electrodes accounting for various percentages of highest node strength occurrences in
1,000 random jackknife resampling networks for three example patients. B: The
location of the most synchronizing region (which is the region with the lowest regional
control centrality), and the regions accounting for various percentages of the most
synchronizing region occurrences in 1,000 random jackknife resampling networks for
three patients. C: Patient-specific synchronizability distributions across resamples.
Each separate violin represents a patient and shows the distribution of synchronizability
values obtained across 1,000 random jackknife resamples. Horizontal black lines show
the original value in the non-resampled network. D: Number of electrodes forming the
95% jackknife confidence electrode set for each nodal metric, for all patients. For each
nodal metric, each dot shows the patient-specific number of electrodes accounting for
95% of all occurrences of the maximum (minimum for control centrality and regional
control centrality) metric value in 1,000 random jackknife resampling networks. For
regional control centrality, this number is divided by the number of electrodes forming
the minimum regional control centrality in the original non-resampled network to obtain
a ratio. E: Width of the 95% jackknife confidence interval for each global metric, for
all patients. For each global metric, each dot shows the patient-specific width of the
95% jackknife confidence interval of the metric value across 1,000 random resamples.
This figure demonstrates the variability in confidence of network theory results across
patients that can be revealed by jackknife resampling.
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4.5 Discussion
Handling missing data is a long-standing problem in science in general and is
particularly problematic in network science, where a missing node may limit our
understanding of the entire network110. In social networks, missing data can dramatically
alter network statistics109,141,142. In the field of neuroscience, Jalili demonstrated that global
efficiency of scalp EEG-based functional networks in healthy individuals was highly
sensitive to the removal of certain nodes143. To our knowledge, this is the first study
examining the reliability of network statistics in the epileptic brain and in iEEG data. We
determined that network measures differ in robustness to spatial subsampling, and that the
sensitivity to sampling does not depend on the distance from the seizure onset zone. We
also found that more extensive implants were more robust to subsampling. Finally, we
developed and applied an algorithm using jackknife subsampling of electrode contacts to
estimate confidence in nodal and global statistics in patient brain networks.
4.5.1 Functional Network Metrics Exhibit Differential Reliability Under Spatial
Subsampling
Metric reliability for all network measures decreased with a greater degree of
missing data, which has previously been reported in social networks142,144. Among
examined nodal metrics, node strength and eigenvector centrality were most reliable and
control centrality was least reliable; among the global metrics we tested, transitivity was
most reliable and synchronizability was least reliable. The difference in reliability across
metrics reflects, in part, the underlying sensitivity of each metric to graph topology. Prior
studies in social networks have also observed that node strength is more robust to
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subsampling than betweenness centrality144,145. The relative robustness of node strength
and eigenvector centrality compared with other nodal measures may reflect that metrics
that primarily incorporate immediate connections to the node of interest are less sensitive
to subsampling than metrics that more strongly weigh multistep connections. The
preserved ordinality of network metric reliability across most patients, timescales, and
frequency bands suggests that this result is generalizable. Clinically, applying network
statistics that are more robust to spatial sampling may be preferable in cases in which the
electrode coverage of important regions is uncertain. The ability of each metric to capture
network behavior must be weighed against its spatial reliability if such personalized models
are to be translated clinically.
Sensitivity to incomplete sampling depends somewhat on the number of electrode
contacts forming the original implantation. Although synchronizability and clustering
coefficient were the only global and nodal measures, respectively, to demonstrate a
significant positive relationship between number of electrode contacts and metric
reliability, all other measures except control centrality demonstrated nonsignificant
positive relationships. This pattern of findings suggests that for most network measures,
greater robustness can be achieved in part through more extensive electrode coverage. This
agrees with work finding that more extensive electrode coverage results in better
predictions of surgical outcome146. Mechanistically, this may imply that random
subsampling is less likely to remove important hubs in larger networks. Alternatively,
perhaps information about missing nodes and edges can be inferred from the remaining
components of the network, which is facilitated by a larger starting network. Clinically,
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this suggests that implanting a greater number of electrode contacts may increase our
confidence in network statistics. This benefit would have to be weighed against the risks
of more extensive coverage, including hemorrhage and infection147. Network metrics were
generally more sensitive to contiguous removal than to random removal of electrodes. This
may reflect spatial correlation of brain signals, such that information from a missing
electrode contact may be more easily inferred from remaining neighbor contacts51,148.
Alternatively, removing contiguous contacts may increase the probability of removing the
entire set of critical electrode contacts that are needed to localize seizure generators. The
analysis removing contiguous electrode contacts may better approximate the clinical
scenario of leaving out an entire electrode or region from sampling, whereas the analysis
removing random contacts better simulates choosing sparser network coverage.
Consideration of which type of “missed coverage” applies in a given clinical context will
inform how strongly that missing coverage may affect network results.
One limitation of the reliability measure as an approximation of metric robustness
to subsampling is that nodal network metrics and their variances across subsampling are
not normally distributed, and so the reliability measure may be disproportionately
influenced by electrode contacts with more extreme values. The fact that nodal metrics had
the same differential ordering in robustness to subsampling as measured by Spearman rank
correlation between the original and subsampled metric supports the validity of the
ordering of nodal metric reliabilities.
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4.5.2 Metric Sensitivity to Incomplete Sampling Is Independent of Distance From the
Seizure Onset Zone
All metrics tested were equally sensitive to removing nodes in close or far
proximity from the clinician-defined seizure onset zone. Most metrics were also equally
sensitive to subsampling that targeted removal of the complete seizure onset zone and
subsampling that spared the seizure onset zone. This may be because the seizure-generating
network is a relatively small subset of the full peri-ictal network, and thus perturbation of
the seizure-generating network has a small effect on the network as a whole. These results
are practically concerning in the case of metrics with lower reliability to spatial
subsampling, such as control centrality and synchronizability, because placement of
electrodes in the network periphery away from clinical zones of interest is often variable
across patients and across epilepsy centers. To increase the clinical confidence in the results
of these network measures, the incomplete network may be supplemented using structural
connectivity data and atlas-based approaches148–150. Network theory also proposes several
methods of predicting missing links110,151. The finding of nonsignificantly increased
sensitivity of the transitivity measure to removing the entire seizure onset zone, along with
a disproportionate increase in transitivity when seizure onset zone electrodes are removed,
may reflect a tendency of nodes in the seizure onset zone to form widespread network
connections peri-ictally. Practically, this finding also suggests that transitivity—and more
specifically, subsampling-induced change in transitivity—is a promising measure to
identify electrodes overlying the seizure onset zone. Of note, the seizure onset zonetargeted versus sparing subsampling method introduces a potential bias in that removing
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the seizure onset zone as opposed to random non-seizure onset zone electrodes
disproportionately targets electrodes that are spatially clustered together. If anything, we
would expect this bias to act to decrease transitivity when seizure onset zone electrodes are
removed, as we might expect electrodes in close proximity to have a higher within-group
clustering and thus increase the overall transitivity of the network.
A limitation of this analysis is that clinical methods for identifying the seizure onset
zone are imperfect, and so the clinician-defined seizure onset zone may not capture actual
seizure generators. When redefining the hypothesized site of seizure generation as the
resection zone (for good-outcome patients) we also found no difference in removing nodes
in close or distant proximity from the resection zone. However, it is possible that neither
method accurately captured true seizure generators.
4.5.3 Jackknife Network Subsampling Generates Confidence Intervals for Virtual
Resection
Prior work has used global and nodal network measures to stratify surgical
candidates and to select nodes for resection52,60,65,93. Here we provide a simple algorithm
to augment these methods by determining patient-specific confidence in the robustness of
estimated statistics to small perturbations in spatial sampling. Similar resampling-based
approaches have been used in social networks152–154, in gene expression data155, and in
resting fMRI data of healthy subjects. The heterogeneity in confidence across patients may
be used to stratify patients into those for whom enough information of the epileptic network
is captured to accurately use personalized network models and those for whom models are
likely to be inaccurate because of implantation strategy. In this study we do not claim to
88

identify the ideal network model among the many published studies. The jackknife
subsampling method may be easily applied to any of these network models.
4.5.4 Methodological Limitations and Future Directions
Our method of network subsampling can examine how networks change only with
the removal of electrode contacts, and not upon the addition of contacts. For an intracranial
EEG study that has parsimoniously captured seizure onset and spread, using our statistical
subsampling method may miss critical electrode contacts and thus erroneously characterize
the network as unreliable. However, for those patients who have very clear seizure onset
and propagation, personalized network models of epilepsy may not be required to guide
surgical planning. An additional limitation is that our measure of nodal metric similarity—
the Spearman rank correlation—may not capture how network model predictions
practically change with subsampling. It is conceivable that a network metric would
demonstrate low reliability to subsampling as defined in this paper, but still generate
consistent predictions about the optimal site of surgical intervention depending on how
these predictions are formed. Different groups have proposed different methods to direct
surgical targeting using network statistics55,65,73,113, and our proposed subsampling method
can be used to test the sensitivity of any targeting predictions to incomplete spatial
sampling, similar to the jackknife procedure described in the section above.
The jackknife analysis results varied somewhat across time, frequency band, and
choice of seizure, reflecting the different states of the network. These observations
underscore the fact that spatial sampling is one of several sources of bias of the network
statistics. Further exploration of the sensitivity of network statistics to the choice of seizure,
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time, and frequency band will be necessary for useful clinical implementation. Also,
additional steps toward translating this work into clinical care will require expanding our
dataset to include larger numbers of patients, stereo EEG implantations, and those treated
with focal laser ablation and perhaps brain stimulation devices.
While in this study we implemented only data-driven metrics that describe
underlying network properties, there is significant interest in fitting generative models of
neural population dynamics to brain networks. One such example, the Epileptor model81,
is a neural mass model that describes many relevant epileptic dynamics and is currently
under study as a clinical trial in Europe to guide epilepsy surgery73. Our network
subsampling approach may also be used for generative neurophysiologic models and gives
confidence to their clinical utility.
4.6 Conclusions
The field of network science provides a promising set of tools for understanding
epilepsy dynamics and for surgical planning. However, the robustness of empirical
estimates of network statistics to incomplete electrode sampling is not well understood. We
have shown variability across network measures in robustness to incomplete sampling.
Network measures are equally vulnerable to removing electrode contacts near versus
distant from the seizure onset zone, and to removing electrode contacts within the seizure
onset zone versus an equivalent number of non-seizure onset zone electrode contacts.
Robustness to incomplete sampling is highly heterogeneous across patients, and jackknife
subsampling is a simple algorithm to obtain patient-specific confidence in the results of
network statistics. The choice of individual network models should be based upon the
90

intended application and on the clinical certainty that important seizure generators have
been sampled by intracranial implants.

4.7 Supplemental materials

Supplemental Figure 4.1. Time dependence of jackknife resampling results. All
data shown is for a single example patient (HUP064). A: The location of the electrode
with the highest node strength, as well as the electrodes accounting for various
percentages of highest node strength occurrences in 1,000 random jackknife resampling
networks at five different time periods. B: The location of the most synchronizing
region, and the regions accounting for various percentages of the most synchronizing
region occurrences in 1,000 random jackknife resampling networks at five different
time periods. C: The distribution of synchronizability values obtained with 1,000
random jackknife resamplings for each time period. Horizontal lines denote
synchronizability in the original non-resampled network. D: The distribution of global
efficiency values obtained with 1,000 random resamplings for each time period.
Horizontal lines denote global efficiency in the original non-resampled network.
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Age Age at
Patient ID Sex onset surgery

Localization Pathology Outcome Grids Strips Depths

HUP064

M 3

22

LFL

MCD

1

64

22

0

HUP065

M 2

36

RTL

MCD

1

64

0

0

HUP068

F

13

28

RTL

MTS

1

63

20

0

HUP070

M 12

33

LFPL

MCD

2

63

0

0

HUP073

M 5

40

RFL

MCD

1

0

52

0

HUP074

F

5

25

LTL

MCD

1

63

29

22

HUP075

F

52

57

LTL

MTS

5

58

34

14

HUP078

M 2 mo

54

LTL

MTS

4

63

24

14

HUP080

F

35

41

LTL

Gliosis

2

62

18

16

HUP082

F

34

56

RTL

MTS

1

64

14

8

HUP083

M 8

29

LPL

Gliosis

2

59

22

0

HUP086

F

18

25

LTL

Gliosis

1

60

32

8

HUP087

M 19

24

LFL

T/V/I

3

60

12

12

HUP088

M 13 mo 24

LFL

MTS

1

0

43

11

HUP094

F

20

48

RTL

Gliosis

2

0

64

20

HUP105

M 27

39

RTL

T/V/I

1

0

43

12

HUP106

F

45

LTL

MTS

2

64

36

16

HUP107

M 5

36

RTL

MTS

1

64

38

16

24

HUP111A F

28

40

RTL

MTS

1

0

32

16

HUP111B F

28

40

RTL

MTS

1

47

42

12

HUP116

51

58

RTL

unknown 1

0

0

50

Study012 M 23

37

RFL

Gliosis

1

57

22

0

Study016 F

36

RFTL

Gliosis

4

47

14

0

Study017 M ?

?

RTL

unknown 4

0

0

16

Study019 M 31

33

LTL

Gliosis

5

60

28

8

Study020 M 5

10

RFL

Gliosis

4

40

16

0

LTL

Gliosis

5

42

12

0

F

Study022 F

5

11-20 21-30

Study028 M 4

5

LFPL

Gliosis

4

64

5

0

Study029 F

?

RTL

Gliosis

5

23

30

8

?

Supplemental Table 4.1. Clinical and electrode information. 2-year surgical
outcomes use the International League Against Epilepsy (ILAE) system (class 1-6).
LFL: left frontal lobe, LFPL: left frontoparietal lobe, LTL/RTL: left/right temporal
lobe, RFTL: right frontotemporal lobe, RFL: right frontal lobe, MCD: malformation of
cortical development; FCD: focal cortical dysplasia, MTS: mesial temporal sclerosis.
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EEC EEC + EEC +
EEC,
EEC,
10 EEC - 5
5
10
EEC, beta contiguous seizure
seconds seconds EEC seconds seconds frequency removal
#2
Control centrality

0.80

0.82

0.84

0.79

0.81

0.80

0.82

0.79

Node strength

0.95

0.95

0.96

0.96

0.96

0.95

0.95

0.96

Betweenness
centrality

0.88

0.89

0.88

0.89

0.88

0.88

0.88

0.89

Eigenvector
centrality

0.95

0.95

0.97

0.96

0.96

0.95

0.94

0.96

Clustering
coefficient

0.94

0.94

0.95

0.95

0.95

0.94

0.91

0.95

Synchronizability

0.95

0.93

0.92

0.93

0.94

0.91

0.85

0.94

Global efficiency

0.98

0.97

0.98

0.99

0.99

0.98

0.92

0.98

Transitivity

0.98

0.97

0.98

0.99

0.99

0.98

0.93

0.97

Supplemental Table 4.2. Metric reliability for alternative conditions. The metric
reliability, defined in the text, for alternative conditions including different time periods
relative to the earliest electrographic change (EEC) (as opposed to the primary analysis
on the EEC), beta frequency coherence (as opposed to the primary analysis on high
gamma frequency coherence), removal of a contiguous set of electrodes (as opposed to
random set), and the second seizure (as opposed to the first seizure).
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EEC EEC + EEC +
EEC,
EEC,
10 EEC - 5
5
10
EEC, beta contiguous seizure
seconds seconds EEC seconds seconds frequency removal
#2
Control centrality

0.80

0.82

0.84

0.79

0.81

0.80

0.82

0.79

Node strength

0.95

0.95

0.96

0.96

0.96

0.95

0.95

0.96

Betweenness
centrality

0.88

0.89

0.88

0.89

0.88

0.88

0.88

0.89

Eigenvector
centrality

0.95

0.95

0.97

0.96

0.96

0.95

0.94

0.96

Clustering
coefficient

0.94

0.94

0.95

0.95

0.95

0.94

0.91

0.95

Synchronizability

0.95

0.93

0.92

0.93

0.94

0.91

0.85

0.94

Global efficiency

0.98

0.97

0.98

0.99

0.99

0.98

0.92

0.98

Transitivity

0.98

0.97

0.98

0.99

0.99

0.98

0.93

0.97

Supplemental Table 4.2. Metric reliability for alternative conditions. The metric
reliability, defined in the text, for alternative conditions including different time periods
relative to the earliest electrographic change (EEC) (as opposed to the primary analysis
on the EEC), beta frequency coherence (as opposed to the primary analysis on high
gamma frequency coherence), removal of a contiguous set of electrodes (as opposed to
random set), and the second seizure (as opposed to the first seizure).
EEC, 80% EEC, 60% EEC, 40% EEC, 20%
Control centrality

0.62

0.70

0.76

0.84

Node strength

0.72

0.84

0.92

0.96

Betweenness centrality

0.62

0.70

0.79

0.88

Eigenvector centrality

0.75

0.86

0.92

0.97

Clustering coefficient

0.60

0.78

0.88

0.95

Synchronizability

0.65

0.77

0.85

0.92

Global efficiency

0.82

0.91

0.95

0.98

Transitivity
0.84
0.91
0.95
0.98
Supplemental Table 4.3. Metric reliability for all removal percentages. The metric
reliability, defined in the text, for all removal percentages tested. All data is shown for
the time period at the EEC.
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EEC EEC +
EEC,
10
EEC - 5
EEC + 5
10
EEC, beta seizure
seconds seconds EEC seconds seconds frequency
#2
Control centrality

-0.09

0.02

0.80

2.64

1.15

0.49

1.06

Node strength

1.47

0.07

1.25

1.30

-0.83

1.76

0.95

Betweenness
centrality

-0.83

-0.22

-0.95

-1.22

0.13

0.04

-0.31

Eigenvector
centrality

1.60

0.22

1.02

1.72

-0.47

1.92

1.37

Clustering
coefficient

1.75

0.02

1.23

1.53

-0.84

1.16

1.22

Synchronizability

-0.30

0.80

-0.26

0.85

0.84

-0.11

-1.06

Global efficiency

2.00

0.79

0.74

0.54

2.31

1.67

-0.61

Transitivity
-0.02
1.43 0.37 0.30
1.70
0.55
-1.39
Supplemental Table 4.4. Association between metric agreement and distance of
removed electrodes from seizure onset zone for alternative conditions. Values
denote the t-statistic evaluating the patient-aggregated Fisher’s transformed Spearman
rank correlations for the distance-agreement associations. The method for calculating
the agreement-distance association is described in the text. Positive values indicate that
the metric is more sensitive to removing electrodes near the resection zone. Values are
shown for different time periods relative to the earliest electrographic change (EEC) (as
opposed to the primary analysis on the EEC), beta frequency coherence (as opposed to
the primary analysis on high gamma frequency coherence), and the second seizure (as
opposed to the first seizure). No association was significant for α = 0.05/8 (Bonferroni
correction).
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EEC, 80% EEC, 60% EEC, 40% EEC, 20%
Control centrality

-0.58

0.61

2.23

0.80

Node strength

0.42

1.53

1.53

1.25

Betweenness centrality

0.74

0.16

0.49

-0.95

Eigenvector centrality

0.47

1.72

1.46

1.02

Clustering coefficient

0.55

1.46

1.44

1.23

Synchronizability

1.28

2.25

0.95

-0.26

Global efficiency

0.34

0.89

0.90

0.74

Transitivity
0.54
0.54
0.55
0.37
Supplemental Table 4.5. Association between metric agreement and distance of
removed electrodes from seizure onset zone for alternative removal percentages.
Values denote the t-statistic evaluating the patient-aggregated Fisher’s transformed
Spearman rank correlations for the distance-agreement associations. The method for
calculating the agreement-distance association is described in the text. Positive values
indicate that the metric is more sensitive to removing electrodes near the resection zone.
Values are shown for different percentages of removed electrodes. All results are for
the time period at the earliest electrographic change (EEC), high gamma frequency
coherence, and the first seizure. No association was significant for α = 0.05/8
(Bonferroni correction).
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EEC - EEC EEC + EEC + EEC,
EEC,
EEC,
10
5
5
10
beta contiguous seizure
seconds seconds EEC seconds seconds frequency removal
#2
Node strength

3

3

3

3

3

4

3

3

Betweenness
centrality

4

4

4

5

5

5

4

4

Eigenvector
centrality

3

4

3

3

3

4

3

3

Clustering
coefficient

3

3

3

3

3

4

3

3

Control centrality

9.5

11

9

8

7

10

6

9

Regional control
centrality

52

51

48

51

47.5

52

50

44

Synchronizability 0.09

0.10

0.09

0.09

0.09

0.09

0.13

0.09

Global efficiency

0.02

0.02

0.02

0.02

0.01

0.02

0.02

0.01

Transitivity
0.01
0.01 0.01 0.01
0.01
0.01
0.02
0.01
Supplemental Table 4.6. Results of jackknife resampling method for alternative
conditions. Each nodal value shows the average number of electrodes accounting for
95% of all occurrences of the maximum metric value (minimum for control centrality
and regional control centrality) across 1,000 jackknife resamples. Each global value
shows the width of the 95% jackknife confidence interval of the network metric across
1,000 jackknife resamples. Values shown are for alternative conditions including
different time periods relative to the earliest electrographic change (EEC) (as opposed
to the primary analysis on the EEC), beta frequency coherence (as opposed to the
primary analysis on high gamma frequency coherence), removal of a contiguous set of
electrodes (as opposed to random set), and the second seizure (as opposed to the first
seizure).
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CHAPTER 5: The effect of iEEG implant geometry on network models
5.1 Abstract
Brain network models derived from graph theory have the potential to guide
functional neurosurgery, and to improve rates of post-operative seizure freedom for
patients with epilepsy. A barrier to applying these models clinically is that intracranial EEG
electrode implantation strategies vary by center, region and country, from cortical grid &
strip electrodes (ECoG), to purely stereotactic depth electrodes (SEEG), to a mixture of
both. To determine whether models derived from one type of study are broadly applicable
to others, we investigate the differences in brain networks mapped by ECoG and SEEG in
a cohort of patients who underwent surgery for temporal lobe epilepsy and achieved a
favorable outcome. We show that networks derived from ECoG and SEEG define distinct
relationships between resected and spared tissue, which may be driven by sampling bias of
temporal depth electrodes in patients with predominantly cortical grids. We propose a
method of correcting for the effect of internodal distance that is specific to electrode type
and explore how additional methods for spatially correcting for sampling bias affect
network models. Ultimately, we find that smaller surgical targets tend to have lower
connectivity with respect to the surrounding network, challenging notions that abnormal
connectivity in the epileptogenic zone is typically high. Our findings suggest that
effectively applying computational models to localize epileptic networks requires
accounting for the effects of spatial sampling, particularly when analyzing both ECoG and
SEEG recordings in the same cohort, and that future network studies of epilepsy surgery
should also account for differences in focality between resection and ablation. We propose
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that these findings are broadly relevant to intracranial EEG network modeling in epilepsy
and an important step in translating them clinically into patient care.
5.2 Introduction
Intracranial electrode recordings from patients with medically-refractory epilepsy
characterize the brain’s local function, widespread network organization, and guide
surgical therapy. From the earliest days of intracranial EEG (iEEG), two major approaches
have been used by clinicians for these purposes. In North America, Penfield’s use of
subdural grid and strip electrodes for electrocorticography (ECoG) persists at many major
centers now decades after its initial use11,156. Meanwhile, centers in France and Italy still
favor Talaraich and Bancaud’s approach of using purely depth electrodes in
stereoelectroencephalography (SEEG) pioneered at St. Anne’s Hospital in Paris12,156.
Recently, many centers in the United States have begun to favor SEEG due to its superior
risk profile and tolerability, though some centers continue to use ECoG for its superior
cortical spatial coverage157. Unfortunately, many patients do not become seizure free after
epilepsy surgery, regardless of implant technique. The reasons for poor outcomes are
unclear, but it is likely in part because the interpretation of intracranial recordings is
complex, subjective, and plagued by sampling uncertainty3. It is also difficult to determine
where and how much of the epileptic network must be resected or ablated to fully prevent
seizures, particularly in cases where there are no obvious lesions on MRI2. Validated,
quantitative methods to guide epilepsy surgery could lead to a greater rate of seizure
freedom and greater clinical benefit to patients.
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Recent evidence supports the hypothesis that epilepsy arises from disordered
connectivity46,158, and that mapping brain networks may aid in both selecting candidates
for invasive treatment and identifying therapeutic targets for surgical resection, ablation or
device implants159. In a brain network model, discrete ‘nodes’ exist either at the sensorlevel for functional connectivity derived from iEEG signals, or at the atlas region-ofinterest (ROI) level for structural connectivity derived from imaging49. Edges quantify the
statistical relationships between nodes in functional connectivity approaches, or streamline
count derived from DTI in structural connectivity. A variety of network methods are being
explored to localize the epileptogenic zone from intracranial EEG data. Such approaches
use interictal51,52,65 or ictal recordings4,55,66,77 and are derived from ECoG52,55,65 or
SEEG105,160 to generate networks. These networks are analyzed using graph theory52,53,55
or neural mass models, which simulate seizure-like activity and probe the effects of
different surgical interventions65,66. Intracranial EEG network models are also used to study
networks activated during normal brain function, for example in recent studies probing
cognition161 and attention162. The majority of these studies use patients implanted with
ECoG, often supplemented with depth electrodes placed in the hippocampus.
Unfortunately, because of the lack of standardization and difficulties in sharing iEEG data
across centers, few studies test their methods in both ECoG and SEEG. In order to validate
and translate network methods into clinical practice across centers, it is important to
understand how these variations in electrode implantation impact estimate connectivity,
subsequent network models and their clinical utility.
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While networks derived from functional MRI and diffusion imaging easily
generalize across patients and centers due to congruence in their full-brain spatial sampling,
iEEG functional networks suffer from sparse sampling and implant heterogeneity. Still, the
problem of spatial sampling bias which affects iEEG networks71 may be offset by: (1) the
superior spatiotemporal resolution of iEEG in implanted regions, compared to functional
neuroimaging and (2) clinical experience that associates particular patterns in the EEG with
typical onset regions, though it can sometimes be difficult to tell if these patterns are the
result of seizure generation or spread. To better translate network models into patient care,
we must better understand the extent of bias or sensitivity introduced by electrode
implantation strategy, in this case ECoG versus SEEG, and its effect on network models.
We must then either change implant strategy or develop computational methods to correct
for this effect. It is important to note that tradition in specific centers is not the only thing
that guides choice of electrode implantation strategy. Other issues, such as the need for
stimulation mapping, characteristics of a lesion such as its type and location, ictal
semiology and suspected clinical syndrome, as well surgeon and epileptologist experience
and training may also factor into approach and electrode choice163.
There are many differences in implantation strategy between ECoG and SEEG that
arise from the electrode hardware itself. Patients implanted with a large ECoG grid will
have regular spacing between contacts in the same electrode (e.g. an 8x8 contact grid),
supplemented with a few additional strip and depth electrodes in other regions, as needed.
The implantation strategy is much more heterogeneous in SEEG. This heterogeneity can
manifest itself in the following ways: (i) a wide range in the number of depth electrodes &
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electrode contacts from center to center, (ii) different spatial orientations and density of
depth electrode implantation, (iii) different assortments of anatomical targets, electrode
spacing and (iv) different levels of implant bilaterality157. Thus, translating network models
into clinical care faces the challenge not only of resolving differences between ECoG and
SEEG approaches, but also a high variability in SEEG approaches from center to center. It
is unclear whether these distinct properties of electrodes and implant strategy preferentially
degrade network representations derived from one approach vs the other, and whether they
preclude using the same analysis for networks derived from SEEG and ECoG.
In this study, we explore the effect of implant strategy in a retrospective cohort of
patients with drug-resistant temporal lobe epilepsy who were evaluated with either ECoG
or SEEG for invasive treatment. We hypothesize the following: (i) ECoG and SEEG
networks have distinct properties due to different patterns of spatial sampling, and (ii)
differences in network properties between ECoG and SEEG will impact the observed
relationship between resected and spared tissue. We aim for our findings to help translate
personalized network models of epilepsy into clinical practice, and to inform other
applications of intracranial EEG connectivity analysis.
5.3 Materials and Methods
5.3.1 Patient data acquisition
We retrospectively analyzed a data set consisting of 33 patients who underwent
intracranial recording during evaluation for epilepsy surgery at the Hospital of the
University of Pennsylvania (HUP). Sixteen of these patients had implants with grid, strip,
and a small number of depth electrodes, while the remaining patients had only
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stereotactically-placed depth electrodes. In this study we refer to cortical-predominant
patients as the ‘ECoG’ group while patients with only depth electrodes constitute the
‘SEEG’ group. All patients underwent either resection or laser ablation after electrode
explant, however in subsequent sections we use the term ‘resected’ tissue to include
ablation patients as well. We chose only patients that achieved good outcome, assessed at
6 months post-operatively, to maximize the likelihood that tissue removed in surgery
contained the epileptogenic zone. Table 5.1 lists subject demographics and characteristics
of therapy and electrode implants. All subjects provided consent to have their full-length
intracranial EEG recordings and anonymized imaging and metadata publicly released on
the ieeg.org portal, an open-source online repository for electrophysiologic studies69,70.
ECoG
16
10

SEEG
17
8

Lesional
Non-Lesional

8
8

10
8

Resection
Laser ablation

14
2

7
11

Total number of subjects
Number of female subjects
MRI*
Type of surgery

p-value
0.49a
0.75a
0.0033a

Node counts
Total GM contacts
Mean ± std. dev. 92.1 ± 21.2
Depth GM contacts

88.6 ± 34.7

0.72b

1.5e-6b
Mean ± std. dev. 10.9 ± 9.3
88.6 ± 35.4
Total GM resected / ablated
0.08b
Mean ± std. dev. 16.9 ± 14.0
9.1 ± 6.0
Depth GM resected / ablated
0.01b
Mean ± std. dev. 4.1 ± 4.8
9.1 ± 6.0
Table 1: Clinical and demographic information. We analyzed a retrospective cohort
of 33 patients with drug-resistant epilepsy who underwent surgery of the temporal lobe
and achieved seizure freedom at 6 months post-operatively. Abbreviations: GM: grey
matter. a = Fisher’s exact test; b = Wilcoxon rank-sum test.
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Each patient underwent a standard epilepsy imaging protocol including pre-implant
MRI, post implant CT & MRI, and post-resection MRI. We have previously described our
method for localizing electrode locations in detail55,87, and briefly summarize them in
Figure 5.1. Post-iEEG-implant MRI (Figure 5.1D) was registered to pre-implant MRI
(Figure 5.1C) using ANTs164 and electrodes are segmented to derive their coordinates using
ITK-SNAP89. Any electrode contacts with centroids outside of the brain in the native MRI
space were eliminated. We then non-linearly registered the pre-implant MRI into Montreal
Neurological Institute (MNI) space for use with neuroimaging atlases, and visually
inspected results for accuracy in each subject. We chose a 90 region AAL atlas165 to assign
each electrode contact location a brain region of interest (ROI). Any electrodes in white
matter with centroids not overlapping with any atlas region were eliminated. Finally, we
used a semi-automated algorithm previously described and validated55 to perform resection
and ablation zone segmentations, which allow the electrode contacts targeted by surgery to
be determined.
5.3.2 Connectivity calculation
We calculated functional connectivity using a pipeline that we have previously
described and validated52,55,77. We randomly selected an interictal segment 1 hour in length
for each patient, occurring at least 1 hour away from clinically-annotated seizures. We
divided the interictal epoch into one-second intervals (Figure 5.1A) and for each window
calculated connectivity using coherence in the beta (15-25 Hz) and low-gamma (30-40 Hz)
bands as well as using broadband cross correlation (after applying 5-115 Hz bandpass and
60 Hz notch filters) as they previously have yielded significant results in interictal network
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studies in ECoG subjects52. We computed the median of each edge over time to obtain a
single adjacency matrix for each patient (Figure 5.1B). Together with the results of our
imaging pipeline, this process yielded networks in which each node is either
resected/ablated or spared in both patients with ECoG (Figure 5.1E) and SEEG (Figure
5.1F).

Figure 5.1. Imaging and network methods: (A) We use artifact-free clips of interictal
iEEG to calculate (B) mean adjacency matrices using multitaper coherence. (C) Preoperative and (D) post-operative T1 weighted MRI are used to segment the resection
cavity which is used to determine resected nodes. (E) Together, we construct networks
with the resected nodes determined in ECoG. (F) SEEG implantations using only depth
electrodes appear distinct even for similar anatomic targets.

5.3.3 Network methods
To probe how network structure differs between ECoG and SEEG we detected
communities using modularity maximization, which labels nodes so that each community
consists of nodes that are more connected to each other and relatively less connected to all
other nodes outside of their community166. We used a Louvain-like method167 to maximize
modularity, which is represented by 𝑄 =

$
QW

∑-/ \𝐴-/ −

I+ I,
QW

] 𝛿(𝑐- 𝑐/ ) , where Aij is link

between nodes i and j, k are edge weights, m is the sum of all edge weights in the graph,
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and 𝛿 is the Kronecker delta function. To compare community structure across patients,
we computed the participation coefficient168 which measures the ratio of a node’s
connectivity strength external versus internal to its module. Averaging participation
coefficient across nodes within each patient yielded an estimate of whether networks are
(i) integrated, with high connectivity between modules, or (ii) segregated, with lower
connectivity between modules.
To illustrate the importance of differences in the way ECoG and SEEG represent
epileptic networks in-vivo, we compared the ability of connectivity derived from these
modalities to distinguish resected and spared tissue. We chose the simple network metric
of node strength, computed as the sum of all edge weights connecting it to all other nodes
and is computed as 𝑠- = ∑%
/2$ 𝐴-/ in which si is the strength of node i, Aij is the adjacency
matrix element containing the edge weight between node j and node i, and N is the number
of nodes. Our group and others have previously demonstrated that high node strength
localizes the epileptogenic zone and predicts surgical outcome in patients implanted with
ECoG52,53, however its translatability to SEEG is not well-established.
5.3.4 Statistical Approach
In our comparisons of network properties between ECoG and SEEG groups we
primarily used nonparametric statistical tests such as the Wilxocon rank-sum test, as they
do not assume that data are normally distributed. To assess the ability for node strength to
detect epileptogenic regions, we used a metric known as the distinguishability statistic (Drs)
which quantifies the area under the receiver operating characteristic curve for classifying
nodes as either resected or non-resected169. The quantity Drs has been previously studied
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and validated for its ability to quantify whether networks have sufficient information to
determine resected or non-resected regions146,169. This value is calculated as the normalized
U-statistic, and ranges from 0-1. In our study, a value of 1 implies that all EZ nodes are
lower in strength than all non-resected nodes; a value of 0 means that all EZ nodes are
stronger than all non-resected nodes; and a value of 0.5 implies that node strength is unable
to distinguish between resected and spared nodes.
5.3.5 Data availability
One of our primary goals is to aid in the translation of epilepsy network models
into clinical practice. To this end, we shared all raw intracranial EEG and imaging data for
HUP patients at iEEG.org, a free cloud sharing platform for electrophysiological data. Each
subject’s recordings are associated with the ID listed in Supplementary Table 5.1 and can
be accessed through the web interface or the open-source iEEG.org MATLAB & python
toolboxes.

The

code

for

calculating

adjacency

matrices

is

available

at

GitHub.com/Akhambhati/echobase, processed adjacency matrices, and code for
comparing networks between ECoG and SEEG is hosted at GitHub.com/jbernabei/
ecog_vs_seeg.
5.4 Results
Here we compared networks mapped by ECoG and SEEG in a cohort of temporal
lobe epilepsy patients. We aimed to describe how each implant approach is biased towards
distinct network properties. We then compared how these distinct network properties
affected how well connectivity could distinguish epileptogenic and non-epileptogenic
regions with the ultimate goal of improved surgical planning.
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5.4.1 Anatomical sampling is similar between modalities
We first asked what differences in the location and extent of anatomic sampling
exist between ECoG and SEEG. After quantifying the top 15 anatomical targets implanted
by each approach (Supplemental Figure 5.1A), we found a similar distribution of electrode
contacts with temporal gyri, hippocampus, and inferior frontal gyri highly sampled. While
the total number of implanted nodes was higher in SEEG compared to ECoG (120.6 ± 41.5
vs. 94.5 ± 22.3, rank-sum p < 0.05), many depth electrodes localized to white matter and
ultimately the number of nodes in grey matter (GM) across ECoG and SEEG was similar
(92.1 ± 21.2 vs. 88.6 ± 34.7, rank-sum p = 0.7, Table 5.1). Ensuring similar node count
was critical for comparing networks and thus for all subsequent analyses we considered
only GM nodes. We observed a slight bias of ECoG to favor ipsilateral sampling with more
nodes than SEEG implanted in the same hemisphere as the resection zone (Supplemental
Figure 5.1B, rank-sum test p = 0.02). The median number of contralateral nodes was higher
in SEEG than ECoG (25 vs. 4), however this did not reach statistical significance
(Supplemental Figure 5.1C, rank-sum p = 0.06). Despite the modest differences in
hemispheric differences in GM nodes, we observed similar median internodal distances
between ECoG and SEEG (Figure S1D, S1E, rank-sum p = 0.2). Overall, the targets
sampled by ECoG and SEEG for patients with temporal lobe epilepsy were similar,
implying that differences in anatomy and internodal distance alone would not primarily
drive any subsequent differences in network models.
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5.4.2 Differences in mapping resected versus spared tissue
Although ECoG and SEEG sample from similar brain regions, they may not
represent the epileptogenic regions similarly from a network perspective. We aimed to
gauge the ability of each implant strategy to distinguish resected and spared tissue using
the distinguishability statistic (Drs). This value is high when resected nodes are weaker than
the spared network and low when they are stronger (Figure 5.2A). Across our cohort, ECoG
patients tended to have a low Drs value while SEEG had higher and more variable values
(rank-sum test, p < 0.01), which was unexpected given that all patients had temporal lobe
epilepsy and achieved good surgical outcome (Figure 5.2B). We then sought to determine
whether the difference network relationship between resected and spared tissue could result
from the frequent placement of depth temporal depth electrodes in ECoG subjects (Figure
5.2C). In these patients we found that resected nodes from surface electrodes had higher
normalized strength than non-resected surface electrodes (rank-sum test, p < 0.01),
however resected depth electrodes were not higher in strength than non-resected depth
electrodes (rank-sum test, p = 0.1). Furthermore, non-resected depth electrodes were higher
in strength than non-resected surface electrodes (rank-sum test, p < 0.01), and resected
depth electrodes were higher in strength than resected surface electrodes (rank-sum test, p
< 0.01). These findings, and the sizable proportion of resected depth electrode contacts in
ECoG could account for the observed difference in Drs values between the two implantation
strategies.

109

Figure 5.2. Network localization. (A) Distinguishability statistic calculated for an
ECoG patient (left) and a SEEG patient (right). In cases where resected node strength
is higher than the remaining network on average, Drs will have a low value, in cases
where resected node strength is lower than the remaining network Drs will be high. A
Drs value of 0.5 means that node strength cannot distinguish resected and spared tissue
(B) In networks of grey matter nodes, Drs of resected and spared tissue is higher in
SEEG compared to ECoG (rank-sum test, p = 0.0026). (C) In patients with ECoG we
found resected nodes from surface electrodes to be higher in strength than non-resected
surface electrodes (rank-sum test, p = 0.0065). Non-resected depth electrodes were
higher in strength than non-resected surface electrodes (rank-sum test, p = 0.0013).
Resected depth electrodes were higher in strength than resected surface electrodes
(rank-sum test, p = 0.0031). Resected depth electrodes were not higher in strength than
non-resected depth electrodes (rank-sum test, p = 0.14). ** = p < 0.01.

5.4.3 Distinct network properties between ECoG and SEEG
We sought next to determine whether we could adequately correct for our findings
of Drs differences between SEEG and ECoG by regressing for internodal distance in an
electrode-specific manner. We fit a nonlinear regression model to ECoG and SEEG
separately (Figure 5.3A) using a rational polynomial (rat11 in MATLAB) which has been
previously validated in interictal network analysis for epilepsy146. Within ECoG we also
used different models for depth-depth connections, surface-depth connections, and surfacesurface connections. Even after correcting for internodal distance, network heterogeneity
was higher in SEEG (Figure 5.3B), represented by a higher standard deviation of edge
weight residuals across the network (rank-sum test, p < 0.01). Furthermore, we calculated
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modularity in distance-corrected networks (Figure 5.3C) and found a higher median
participation coefficient in SEEG representing higher network integration (rank-sum test,
p < 0.01). Analogous results for broadband cross – correlation and low – gamma coherence
are found in Supplementary Figure 5.3. These results indicate that despite accounting for
internodal distance and the effects of distinct electrode types on connectivity, differences
in global network properties remain.

Figure 5.3. Global network structure is impacted by sampling differences between
ECoG and SEEG. (A) We fit a nonlinear regression model to ECoG surface – surface
(dotted blue line), surface – depth (dashed blue line), and depth – depth connections
(solid blue line), as well as SEEG depth – depth connections (solid red line). (B) After
correcting for internodal distance, the standard deviation of edge weights remained
higher in SEEG versus ECoG (rank-sum test p = 0.0052). (C) After correcting for
internodal distance, the median participation coefficient remained higher in SEEG
versus ECoG (rank-sum test p = 0.0018). Abbreviations: S-S: surface – surface, S-D:
surface – depth, D-D: depth – depth, SD: standard deviation, ** = p < 0.01.
5.4.4 Modifying ECoG and SEEG networks to correct for sampling bias
We finally asked how our internodal distance correction would affect resection
zone distinguishability in ECoG and SEEG, and whether we could correct for any
remaining differences in network localization by simplifying initial networks to reduce
sampling differences. Due to the different balance of ipsilateral and contralateral nodes in
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ECoG and SEEG (Supplemental Figure 5.1B & C) and the distinct connectivity of intravs inter-hemispheric edges, we hypothesized that eliminating nodes contralateral to the
resection zone of distance-corrected networks could improve localization. Based on the
distinct modular structure of ECoG and SEEG, we additionally hypothesized that
averaging all edges between pairs of brain regions and thus reducing nodes from
representing electrode contacts to representing atlas-level regions of interest (ROI) could
correct for different balances of connectivity within and between modules. We performed
each of these steps for all ECoG and SEEG patients (Figure 5.4A).
We then calculated Drs for each of the three modifications (i) correction for
internodal distance (DC), (ii) using only unilateral nodes ipsilateral to the resection zone
(UL), and (iii) atlas-level ROI (AR) (Figure 5.4B). For each condition, SEEG networks
had a higher Drs value than ECoG: GM ECoG vs. GM SEEG, as in Fig. 2B: rank-sum test
p < 0.01, DC ECoG vs. DC SEEG: rank-sum test p < 0.01, UL ECoG vs. UL SEEG: ranksum test p < 0.01, AR ECoG vs. AR SEEG: rank-sum test p = 0.02. Each condition in
ECoG and SEEG also had a higher Drs value than in uncorrected networks (DC / UL / AR
ECoG vs GM ECoG: sign-rank test p < 0.01 for each, DC / UL / AR SEEG vs GM SEEG:
sign-rank test p < 0.001 / 0.001 / 0.01). Analogous results for broadband cross – correlation
and low – gamma coherence are found in Supplementary Figure 5.2. The atlas-ROI
representation had the highest median distinguishability in ECoG compared to the base
network, however SEEG patients had higher Drs values compared to ECoG even for this
condition. As ECoG and SEEG networks with distance-corrected, unilateral, ROI-level
nodes should be as similar as possible, we hypothesized that remaining differences were a
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result of differences in the extent of surgical intervention between groups (Table 5.1).
Indeed, across ECoG and SEEG, we found a strong, negative correlation between Drs
values and the number of atlas ROI nodes resected (Pearson correlation rho = -0.48, p <
0.005, Figure 5.4C). This finding suggests that the network relationship between resected
and spared tissue depends on the focality of the surgical approach.

Figure 5.4. ECoG and SEEG have distinct representations of the epileptogenic
zone. (A) We used three approaches to modifying networks to probe sampling
differences between ECoG and SEEG and their effect on distinguishing resected and
spared tissue. We corrected for the effects of internodal distance (DC). Then, we
eliminated nodes contralateral to the resection zone (UL). Finally, we averaged edges
between pairs of brain regions to have a single node per atlas-level region of interest
(AR). (B) We compared the effect of correcting for internodal distance to unilateral to
atlas ROI representations. For each condition, SEEG networks had a higher Drs value
than ECoG. Each condition in ECoG and SEEG also had a higher Drs value than not
accounting for internodal distance. GM ECoG vs GM SEEG, as in Fig. 2B: (rank-sum
test p = 0.0065), DC ECoG vs DC SEEG: (rank-sum test p = 0.0059), UL ECoG vs UL
SEEG: (rank-sum test p = 0.0047), MR ECoG vs MR SEEG: (rank-sum test p = 0.022).
DC/UL/AR ECoG vs GM ECoG: (sign-rank test p = 0.0027/0.0061/0.0011),
DC/UL/AR SEEG vs GM SEEG: (sign-rank test p = 0.0006/0.0008/0.0031). (C) Drs
values of min-ROI networks were negatively correlated with the number of ROI that
contained electrode contacts in the resection zone (Pearson correlation p < 0.005).
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5.5 Discussion
Understanding the sampling differences of different implant approaches is critically
important when applying network models to interpret iEEG data. Here, we showed how
unique characteristics of ECoG and SEEG sampling result in distinct properties of derived
networks despite similar clinical targets. Node strength, a frequently studied network
metric in epilepsy, had an unpredictable relationship between resected and spared tissue,
and accounting for internodal distance & electrode type still resulted in distinct network
properties. We also establish that these general patterns are present in different frequency
bands and in both coherence and correlation measures of functional connectivity. Finally,
we provided several methods to partially mitigate the effects of sampling bias introduced
by implantation strategy on network models, and showed that remaining differences are
associated with the focality of the subsequent resection or ablation.
Our study adds to the growing body of literature on methodological considerations
for applying network models clinically71,146. From these studies, we recognize that a major
challenge in applying network models to the epileptic brain is determining whether
observed patterns in brain activity and therefore network structure truly capture the
phenomena of interest, and to what extent they arise from sampling artifact. To this end,
we must acknowledge that the sampling bias in both ECoG and SEEG is distinct, and that
subtle differences in the arrangement of electrodes can determine whether connectivity can
accurately uncover true pathology. Thus, sampling bias is more complex than just whether
or not a particular target was sampled, and we must take special care to ensure that models
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are not biased by the locations of electrodes selected by physicians to simply confirm a
priori suspicions present before implant.
While the finding that ECoG and SEEG have distinct network connectivity patterns
in resected versus spared tissue is significant, it may in part reflect conceptual differences
underlying these implant strategies. ECoG attempts to map the boundaries of epileptogenic
cortical regions by assessing seizures and interictal activity12, while SEEG focuses on
‘electro-anatomo-clinical’ correlations12, in which broader network mapping and the
relationship of anatomical spread to seizure semiology is important. For these reasons, as
well as the typical use of a single electrode type & geometry, that SEEG may be superior
from a network perspective as the inherent conceptualization of the modality takes the
network approach in mind170. In particular, reducing networks to atlas ROI nodes as we
present here may be an appealing approach for this type of mapping in the future, since
these regions and their connections correspond to anatomically relevant and interpretable
structures. Such an approach could also facilitate the integration of findings from
intracranial EEG networks with studies of quantitative imaging such as fMRI and DTI
which typically use atlas ROI nodes, or through the use of intracranial EEG atlases for the
prediction of missing information148,171.
While others have reported differences in connectivity values between depth
electrodes and surface electrodes172, the potential scientific and clinical relevance of
network differences that arise as a result of these are significant. It is likely that this finding
underlies the results of Figure 5.2B, that in uncorrected networks of ECoG which often
include temporal depths, connectivity of resected tissue is relatively strong whereas in
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SEEG it is variable. Indeed, in cases of suspected temporal lobe epilepsy mapped by ECoG,
the chance that depth electrodes will capture the seizure onset zone is high. Furthermore,
the different physical size and cylindrical shape of each electrode contact in SEEG
compared to ECoG records local fields from different types of neural populations which
could have distinct coherence values. Overall, this observation is likely fixed by
performing separate internodal distance corrections for depth and cortical electrodes, which
adds to the literature that regressing for internodal distance improves outcome
prediction146.
The results of our sampling correction process (Figure 5.4) reveal interesting
aspects of sampling differences between ECoG and SEEG. The finding that eliminating
nodes contralateral to the resection zone doesn’t significantly change localization from
bilateral distance-corrected networks, implies that this issue is not a major factor driving
why certain models may succeed or fail in some patients. Indeed, most subjects do not have
symmetric implants but rather have a bias towards the hemisphere with the most clinical
correlates. Contralateral electrodes are often placed to address clinical hypotheses of
lateralization, and due to their relative isolation from the bulk of electrodes, it is possible
that they are already outliers in the network and do not contribute highly to the outcome of
the distinguishability statistic. On the other hand, if the true epileptogenic zone is in the
hemisphere with fewer electrodes, network models may struggle with localizing it.
Furthermore, our finding that averaging edges between pairs of brain regions to convert
nodes to atlas ROIs maintains similar performance implies that network models may not
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need dense sampling within regions, but instead may benefit from sampling inter-regional
connections.
Another important consideration to the application of network models is the issue
of surgical focality which may differ significantly between resection and ablation patients.
While many previous studies focus on resection patients, which may extend to natural
anatomic boundaries therefore removing additional, non-epileptogenic tissue, a large part
of our cohort underwent ablation in which lesions are relatively small and more specific to
the epileptogenic zone. Indeed, others have found that a large number of nodes within and
outside of the resection zone is important for accurate outcome prediction from interictal
connectivity, which may be impossible for ablation patients. In this context, our finding of
a negative correlation between Drs and number of regions targeted may imply that the truest
representation of the epileptogenic zone is of low node strength relative to the rest of the
brain. This notion is supported by studies demonstrating cellular loss in these regions,
particularly the hippocampus, in temporal lobe epilepsy173,174. As minimally-invasive
approaches such as laser ablation become more common, it is important that our notions
of network abnormalities and methods of localizing the epileptogenic zone and outcome
prediction do not rely too heavily on findings from resection patients alone.
Despite its encouraging results in illuminating the differences between ECoG and
SEEG networks, our study has several key limitations. We focused our analysis on node
strength, one of the simplest graph theory metrics that has been studied frequently in
epilepsy, so this measure may not fully represent the complexity of abnormal networks in
this disorder. However, given that node strength is among the least sensitive network
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metrics to sampling bias71, we felt that it was a reasonable choice to compare these
approaches. Furthermore, It is well known that node strength is correlated with other
network centrality metrics175 and even certain phenomenological network models which
employ dynamical systems linked by functional connectivity65. Thus, many of the
principles we highlight here may be broadly generalizable to other network studies in
epilepsy, and future work should account for sampling bias where possible. Another
limitation is our consideration of a single 1-hour iEEG segment, which does not capture
the variability in interictal activity and thus connectivity which is known to follow
circadian172 and slower timescales176. However, sleep-wake cycles may be interrupted and
difficult to estimate in the epilepsy monitoring unit when sleep deprivation and medication
withdrawal are common, and hospital admissions are too short to capture predominant
multi-day cycles which are close to a month long in many patients. A final limitation is our
analysis of only temporal lobe epilepsy patients. We chose this cohort to minimize
variability within and across groups and because they represent the largest number of
patients at our center. However, distinct patterns of sampling bias may exist in
extratemporal epilepsies. Future work should address whether the relationship of
connectivity in other anatomical locations of the epileptogenic has a similar pattern to
temporal lobe epilepsy, and whether these patterns are also different in ECoG versus
SEEG.
Ultimately, clinical judgement of risk and reward will drive the choice between
ECoG and SEEG for individual patients. While the path of clinical translation for network
models is complicated by inherent sampling biases across techniques and varying surgical
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practice among institutions, we believe it is vital to compare and contrast studies of ECoG
and SEEG and recognizing that each provides a distinct view of the brain’s underlying
connectivity but that neither are ‘correct’. Finally, we believe that carefully understanding
the sampling properties of networks mapped by intracranial EEG can extend the use of
graph theory to broader problems in translational human neuroscience.
5.6 Supplemental materials

Supplemental Figure 5.1. Anatomic distribution of electrodes is similar in ECoG
and SEEG: (A) The top 15 ranked AAL regions in terms of total number of electrodes
across patients. Green: ipsilateral, Purple: contralateral. Abbreviations: Mid: middle,
Inf: inferior, Sup: superior, Tri: pars triangularis, Oper: pars opercularis, Orb: pars
orbitalis. (B) The number of grey matter nodes ipsilateral to the resection zone was
higher in ECoG (median: 93) versus SEEG (median: 64), (rank-sum test, p = 0.022).
(C) Comparing the number of grey matter nodes contralateral to the resection zone
between ECoG (median: 4), and SEEG (median: 25) did not reach statistical
significance (rank-sum test, p = 0.057). (D) Distribution histogram of internodal
distances in ECoG (blue) and SEEG (red). (E) The median internodal distance in each
patient was not significantly different between ECoG (median: 62.2) versus SEEG
(median: 70.2), (rank-sum test, p = 0.24).
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Supplemental Figure 5.2. Network connectivity in alternate frequency bands: Data
for broadband cross-correlation (CC) are on the top row, and low-gamma (LG)
coherence is on the bottom row. (A) Median connectivity values were not significantly
different between ECoG and SEEG for broadband cross-correlation (rank-sum test p =
0.17), but SEEG had higher low-gamma coherence (rank-sum test p = 1.9e-4). (B) We
fit a nonlinear regression model to ECoG surface – surface (dotted blue line), surface –
depth (dashed blue line), and depth – depth connections (solid blue line), as well as
SEEG depth – depth connections (solid red line). (C) After correcting for internodal
distance, the standard deviation of edge weights remained higher in SEEG versus ECoG
for low-gamma coherence (LG rank-sum test p = 0.0013) but not broadband crosscorrelation (CC rank-sum test p = 0.10). (D) After correcting for internodal distance,
the median participation coefficient remained higher in SEEG versus ECoG (CC ranksum test p = 0.0026, LG rank-sum test p = 8.5e-4). Abbreviations: NS = not significant,
S-S: surface – surface, S-D: surface – depth, D-D: depth – depth, SD: standard
deviation, ** = p < 0.01, *** = p < 0.001.
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Supplemental Figure 5.3. Distinguishability of resected versus spared tissue in
alternate frequency bands: We computed distinguishability for the different networks
derived from ECoG and SEEG (Figure 4A), including only grey matter (GM), distance
corrected (DC), networks with contralateral nodes eliminated (UL), and networks with
atlas-level ROI (AR). (A) For broadband cross-correlation in each condition, SEEG
networks had a higher Drs value than ECoG. Each condition in ECoG and SEEG also
had a higher Drs value than not accounting for internodal distance. GM ECoG vs GM
SEEG: (rank-sum test p = 0.0042), DC ECoG vs DC SEEG: (rank-sum test p = 0.024),
UL ECoG vs UL SEEG: (rank-sum test p = 0.029), AR ECoG vs AR SEEG: (rank-sum
test p = 0.029), DR/UL/MR ECoG vs GM ECoG: (sign-rank test p =
0.0023/0.0072/0.0131), DC/UL/AR SEEG vs GM SEEG: (sign-rank test p =
0.0012/0.0019/0.0075). (B) For low – gamma coherence: SEEG networks had a higher
Drs value than ECoG. Each condition in ECoG and SEEG also had a higher Drs value
than not accounting for internodal distance. GM ECoG vs GM SEEG: (rank-sum test p
= 9.8e-4), DC ECoG vs DC SEEG: (rank-sum test p = 0.0059), UL ECoG vs UL SEEG:
(rank-sum test p = 0.0090), AR ECoG vs AR SEEG: (rank-sum test p = 0.014).
DC/UL/AR ECoG vs GM ECoG: (sign-rank test p = 0.0009/0.0027/0.0052),
DC/UL/AR SEEG vs GM SEEG: (sign-rank test p = 0.0007/0.0010/0.0245).
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CHAPTER 6: An atlas of normative iEEG activity and connectivity
6.1 Abstract
Recording seizures using intracranial EEG (iEEG) is an essential tool for surgical
planning for patients with refractory epilepsy. Quantitative measures of interictal iEEG are
potentially appealing biomarkers, however their utility is limited by the sparsity electrode
implantation as well as the confounds of normal neural activity and connectivity which
vary spatiotemporally. We propose that leveraging a large number of patients to construct
a normative atlas of intracranial EEG activity and connectivity will allow us to reliably
map abnormal regions, thereby serving as a tool to increase our understanding of epilepsy
and identify better targets for epilepsy surgery. We aggregated interictal iEEG
retrospectively across 166 subjects comprising >5000 channels. For each channel, we
calculated normalized spectral power, wavelet entropy, Pearson correlation, and
coherence. We constructed an iEEG atlas by mapping the distribution of each feature
across the brain, and test the atlas by generating a Z-score for each channel of novel
patients. This procedure can reliably identify quantitative abnormalities in clinically
relevant areas such as the seizure onset zone (SOZ) and irritative zone. We show that for
SOZ within the amygdala and hippocampus, measures of connectivity abnormality are
more enhanced than univariate measures of abnormal neural activity. We also find that
patients with lesional MRI have a greater level of abnormality in the SOZ compared to
non-lesional patients. We input the Z-scores of each metric to a random forest classifier to
determine whether channels are likely to be in the SOZ. By integrating measures of both
single-channel activity and inter-regional functional connectivity, we find a better accuracy
in predicting the SOZ versus normal brain (area under the curve = 0.81) compared to either
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group of features alone. The findings of this study serve to directly increase our
understanding of the relationship between abnormal neural activity, connectivity and
epilepsy, and our methods establish a framework for leveraging big data in surgical
planning. Finally, we publicly share our atlas so that others may build upon the data and
methods which we present here.
6.2 Introduction
Over 20 million individuals worldwide have drug-resistant epilepsy10, and for these
patients surgical resection provides the best chance of seizure freedom177. However, up to
40% of patients relapse after surgery, indicating an insufficient understanding of how
seizures arise from the epileptic brain as well as the difficulty of interpreting multimodal
data including intracranial EEG (iEEG) which is traditionally used in surgical planning.
Another limitation of iEEG the cost and morbidity associated with lengthy hospital stays
in specialized epilepsy monitoring units to wait for seizures to occur. Furthermore, as such
seizures are typically rare events, the seizure onset zones observed during iEEG may not
constitute all brain regions capable of generating seizures, known as the epileptogenic
zone12, a mismatch which could lead to the sub-optimal selection of surgical targets and
poor surgical outcomes. A reliable, interictal biomarker of the epileptogenic zone could
reduce the need for extended recording and the reliance on precipitating seizures to guide
epilepsy surgery.
Epilepsy results in specific patterns of interictal activity that may occur in
epileptogenic regions, such as spikes178 and high frequency oscillations179. While these
events may provide some localizing value in surgical evaluation180,181, they have not proven
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to be specific enough to serve as reliable biomarkers alone182. Spikes can be generated
across many regions which are unnecessary to resect for a good surgical outcome183.
Similarly, HFOs are not always pathologic and may localize outside of epileptogenic
tissue184, making them unlikely to replace seizure onset zone identification as the gold
standard of surgical evaluation. Beyond these paroxysmal events, epilepsy may also result
in focal differences in baseline rhythmic activity such as slowing185. More work is needed
to establish sensitive and specific interictal biomarkers of the epileptogenic zone that
generalize across a wide range of etiologies and locations of focal epilepsy.
Besides manifesting abnormal neural activity, the seizure onset zone also comprises
part of an abnormal network that is increasingly recognized as an essential aspect of
epilepsy pathophysiology47. This pattern exists across spatial scales at both the structural186
and functional51,52 level, and occur not only during seizures54,55 but also at rest65. Methods
of mapping connectivity for surgical planning based on neuroimaging suffer from poor
temporal resolution, and those based on intracranial EEG suffer from sampling bias
introduced by electrode number and placement71,187. Beyond sampling bias, quantitative
methods of mapping epileptic networks are confounded by normal spatial patterns of neural
activity171 and neural connectivity148 which vary across the brain. Neuroimaging studies
avoid this problem by leveraging identical, full-brain spatial sampling across patients and
comparing subjects with epilepsy to healthy controls. Conversely, iEEG is very rarely used
in patients without epilepsy and always has incomplete coverage, so traditional normative
mapping is impossible. However, recent work has provided methods for aggregating multipatient iEEG data to attempt normative analyses of full-brain univariate neural
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activity171,188, and bivariate neural connectivity148, which may serve as a powerful methods
of leveraging big data to map epileptogenic abnormalities using iEEG in patients with drugresistant epilepsy.
Here, we propose and validate a framework for mapping epileptogenic
abnormalities across the brain by leveraging two large cohorts of iEEG. Using a previously
published, multi-center dataset171 and one that is novel to our study, we construct a
normative atlas of iEEG activity and connectivity. We hypothesize that deviations in these
metrics from the normative estimates are reliable markers of the seizure onset zone, and
that capturing both focal and inter-regional abnormalities provides the most localizing
value. While we expect that the atlas approach will require more data before it can serve
as a reliable clinical tool, we aim to highlight its utility as an alternative to traditional iEEG
analysis, and also release our data for others to build upon.
6.3 Methods
We retrospectively analyzed data from 166 patients with drug resistant epilepsy.
Sixty of these subjects underwent iEEG implantation as part of epilepsy surgery at our
center, the Hospital of the University of Pennsylvania (HUP). As no single center has a
high enough volume to support the construction of an iEEG atlas, we leveraged a highquality, publicly available dataset of 106 subjects to increase the amount of normative data.
These patients received iEEG at the Montreal Neurologic Institute (MNI) and two other
centers, and 1772 channels of their data were judged as clinically normal and released as
the MNI Open iEEG Atlas (https://mni-open-ieegatlas.research.mcgill.ca)171. Across the
multicenter cohort, each patient underwent implantation with subdural grid & strip
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electrodes (ECoG), only depth electrodes (SEEG), or a mixture of both. At HUP, all
subjects underwent either resection or laser ablation after electrode explant.

Number of patients
Sex
Female
Male
Laterality
Right
Left
Pre-surgical MRI
Lesional
Non-Lesional
Age onset
Age surgery
Target
Temporal
Frontal
Insular
Implant type
ECoG
SEEG
Surgery type
Resection
Ablation

Latest surgical outcome
Engel 1
Engel 2+
p-value
38
22
0.46a
17
12
21
10
0.50a
19
9
19
13
0.05a
22
7
16
15
0.63b
14.9 ± 11.7 17.5 ± 14.5
0.69b
38.8 ± 10.8 35.2 ± 11.8
0.41a
28
14
7
6
1
2
0.008a
20
4
18
18
0.01a
25
7
13
15

Node count
Total in grey matter 82.1 ± 25.1 91.8 ± 30.5
0.16b
Removed 12.3 ± 10.7 8.5 ± 6.2
0.12b
Initially Engel 1 before relapse
N/A 8
Table 6.1. Atlas patient dataset. Patients were grouped by initial surgical outcome.
Left column shows patients that achieved Engel 1 outcome at 6 months Right column
shows that had poor surgical outcome at 6 months. Statistical tests: a rank-sum test;
b Pearson chi-square test.
We also determined surgical outcome on the Engel scale at a minimum of 6 months after
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surgery, and at the 12 & 24 month post-operative interval for the majority of patients. All
subjects consented to data collection & sharing, and we performed all research in
concordance with protocols approved by the institutional review board of the University of
Pennsylvania. The overall characteristics of the HUP cohort are described in Table 6.1..
6.3.1 Data selection
To ensure that data from our center could be compared and combined with MNI
data, we implemented a rigorous data selection process that closely followed the goldstandard methods of Frauscher et al., 2018171. We selected 60 seconds of data (Figure 6.1A)
in two 30-second clips for each subject that met the following criteria in order of priority:
(i) Free of artifact, (ii) at least two hours before the beginning of a seizure, and at least two
hours after a subclinical seizure, six hours after a focal seizure, or twelve hours after a
generalized seizure, (iii) free of spikes, and (iv) not within the first 72 hours of recording
to minimize immediate implant and anesthesia effects. All selected clips met conditions (i)
and (ii), and the vast majority of clips met conditions (iii) and (iv). We used clips that
captured awake brain activity, determined both by the selection of daytime epochs and the
use of a custom non-REM sleep detector developed using MNI data and validated on HUP
data. Specific details of the sleep detector approach and performance are included in
Supplementary Methods 1. As our study centers around identifying clinically normal and
abnormal regions, we also used a validated algorithm to detect and quantify spikes180. We
consider a region that generates at least 1 spike per hour to be part of the irritative zone. A
sample of 50 spike detections was manually examined by a fellowship-trained neurologist
for positive predictive value. We also recorded clinically-determined seizure onset zones
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that were used in surgical evaluation. Similar to the MNI dataset, we define an abnormal
channel as one that is within the seizure onset zone, irritative zone, or was within the
resection zone. Between HUP and MNI atlases, we have 2630 channels which are clinically
normal, and 2577 HUP channels which are clinically abnormal (Figure 6.1B).

Figure 6.1. Project overview. (A) Interictal iEEG in 166 subjects (106 MNI, 60 HUP).
All data was determined to come from awake subjects, SOZ, irritative zone, and surgical
outcome. (B) All channels from Engel 1 patients that were outside of the irritative zone
and seizure onset zone were considered clinically normal, amounting to 2305 channels.
All channels from Engel 2+ subjects, and all channels from irritative zone and seizure
onset zone were considered clinically abnormal, comprising 1851 channels. (C) For
each channel, we calculated univariate features of normalized spectra power from 0.580 Hz, as well as wavelet entropy (D) We also calculate connectivity using band-limited
Pearson correlation and coherence (E)We construct an intracranial EEG functional atlas
by mapping the distribution of each univariate feature within an anatomical ROI, and
each bivariate feature between pairs of ROI (F)We test the atlas by generating a Z-score
for each feature in each node (or pair of nodes for bivariate features) of a test patient.
(G) We use the Z-scores of each metric as input for a random forest classifier to
determine whether individual channels are likely to be in the SOZ.
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6.3.2 Patient imaging
Each HUP patient underwent a standard epilepsy imaging protocol including preimplant MRI, post implant CT, and post-resection MRI. Post-iEEG-implant MRI is
registered to pre-implant MRI using ANTs164 and electrodes are segmented and to derive
coordinates using VoxTools87 and ITK-SNAP89. We then register the pre-implant MRI into
Montreal Neurological Institute (MNI) space for use with neuroimaging atlases. We finally
use a semi-automated algorithm previously described and validated to perform resection
and ablation zone segmentations which determine the electrode contacts targeted by
surgery. The MNI Open iEEG Atlas data contained MNI coordinates of each electrode as
well and all electrode contacts were localized using the AAL atlas165. However, we
eliminated regions that are not typically targeted by iEEG, including the cerebellum and
basal ganglia, and further aggregated neighboring gyri in regions with low sampling (such
as occipital lobe) to increase the samples in each region, thus reducing the sparsity of our
atlas. This process and the resulting ‘reduced’ atlas which we will use for the rest of this
study is shown in Supplementary Figure 6.1, and contains 20 regions in each hemisphere.
6.3.3 Signal processing
We first montaged the HUP data into a bipolar configuration to match that of the
MNI Open iEEG Atlas. We used a first order Butterworth filter with the passband between
0.5 and 80 Hz to remove high-frequency oscillations as well as a 60 Hz IIR notch filter to
remove noise, and down-sampled the data to 200 Hz from its original 512 or 1024 Hz
sample rate to match the MNI atlas. We excluded any channels contaminated by excessive
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noise as well as bipolar pairs in which both contacts were located in white matter, or either
contact was located outside of the brain.
For each channel, we calculated the power spectral density (Figure 6.1C) using
Welch’s method189 with a 2-second Hamming window and a 1 second overlap. We
normalized the spectral density to have a sum of 1 as surface and depth electrodes may
have different signal amplitude, but have preserved frequency content171. We calculated
normalized spectral content in the following frequency bands: delta (0.5-4 Hz), theta (4-8
Hz), alpha (8-12 Hz), beta (12-30 Hz), and gamma (30-80 Hz). We also applied separate
bandpass filters (first order Butterworth) to extract the oscillatory components of the signal
corresponding to each of the aforementioned canonical frequency bands and calculated
median Shannon wavelet entropy190 across 1-second windows of each channel’s 60
seconds of data.
6.3.4 Connectivity calculation
We calculated functional networks within each patient (Figure 6.1D) using Pearson
correlation and coherence between each pair of N channels to yield N x N adjacency
matrices. For Pearson correlation, we used first-order Butterworth filters to limit
connectivity to each of the five frequency bands as discussed above, with resulting
connectivity values ranging from -1 to 1. We calculated band-limited coherence, which
could range from 0 to 1. For each method, we divided the interictal epoch into one-second
intervals and computed the median of each edge over time to obtain a single adjacency
matrix for each of the ten feature-connectivity pairs (five frequency bands each of
correlation and coherence) in each patient.
130

Figure 6.2. Construction of a multi-subject functional connectivity template. (A)
The median connectivity (band-limited coherence and correlation) is calculated within
each patient across 1-second windows (B) After excluding clinically abnormal
channels, all edges between each pair of ROI are aggregated across subjects to construct
a functional connectivity atlas. (C) For each patient, each edge is Z-scored against the
distribution of edges corresponding to the appropriate brain regions in the atlas. Any
edges in the ‘test’ patient that are not captured in the atlas are not assigned a Z-score
and are excluded from further analysis. (D) This process yields an adjacency matrix of
edge abnormality Z-scores. (E) Taking the 75th percentile of all absolute edge Z-scores
for each node gives a single measure of nodal connectivity abnormality for each
connectivity metric.

6.3.5 Atlas construction & testing
Our approach to normative iEEG mapping requires the separation of clinically
normal channels and abnormal channels. We assigned each channel to a region of interest
(ROI) in the reduced atlas we described above. Each region therefore has a distribution of
values for each univariate feature comprised of all normal channels localized to that ROI
(Figure 6.1E). We describe our connectivity-based methods figure 2. From the median
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adjacency matrix of each patient (Figure 2A), representing the connections between each
electrode contact, we use assign each node a location in the common MNI 152 space, and
subsequently a ROI of the reduced atlas (Figure 6.2B). For any region pairs which only
have fewer than five edges measured across patients we eliminate them from further
analysis as their variance estimate is unlikely to be accurate. We further exclude edges
which are partially or fully involve nodes which were judged to be clinically abnormal.
Our final step in atlas construction is to take the median and standard deviation of each
edge across all good outcome patients to yield final matrices corresponding to the expected
iEEG connectivity and its variability across patients which serves as our atlas.
6.3.6 Atlas testing & statistical methods
To measure central tendency, we typically use the median as it is more sensitive to
outliers. We also log-transformed entropy and coherence features so they would
approximate normal distributions, while spectral density and correlation features did not
require this step. To map the abnormality across intracranial EEG functional connections,
we use the atlas as a look-up table to determine whether each individual connection in a
‘test’ patient is likely to be normal or abnormal. For each inter-regional edge, we determine
its Z-score against the atlas median and standard deviation of connectivity between that
same pair of brain regions (Figure 6.2C). Any connections which are unmeasured in the
atlas are not assigned Z-scores and are left blank. As we are primarily concerned about the
level of abnormality, we took the absolute value of all Z scores to yield a magnitude. As
connectivity measures operate at the edge level (Figure 6.2D) rather than the node level
which would complicate analysis, we reduced connectivity abnormality to a single value
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for each feature-node pair by taking the 75th percentile of absolute Z-score across all edges
for each node (Figure 6.2E). This allows the abnormality scores of connectivity and activity
to be interpreted similarly. From all absolute Z-scores of univariate and bivariate features
(Figure 6.1F), we use a random forest model to identify the seizure onset zone (Figure
6.1G). We use 10-fold cross-validation over normal versus seizure onset zone channels, in
which the 20 input features for each channel correspond to 5 bands for each of normalized
spectral density, log entropy, correlation, and coherence. We quantify performance using
the receiver operating characteristic curve, and compare the performance between the full
feature set and using only univariate or only bivariate features.
6.3.7 Code & Data sharing
In the interest of helping network techniques such as ours reach clinical practice,
we share all code and data from this study. All pre-implant, post-implant, and postresection or ablation imaging as well as full intracranial EEG records are available at
ieeg.org under the project iEEG_atlas. All code as well as .mat files containing the
processed atlas adjacency matrices, and information about clinical metadata is available at
GitHub.com/iEEG_atlas. The HUP Open iEEG Atlas file is available at Pennsieve, with a
similar structure to the MNI Open iEEG Atlas. A description of each of the data fields
contained within the file is available in Supplemental Table 6.1.
6.4 Results
6.4.1 Validating the HUP Open iEEG Atlas
We first sought to determine whether features of the HUP atlas were similar to the
MNI atlas to test whether their normative data and ours could be seamlessly combined. We
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compared the median normalized spectral density in each frequency band and each brain
region (aggregating nodes from the same region in each hemisphere) between datasets
using the rank-sum test and adjusted the significance level to a = 0.0005 to correct for 100
comparisons (20 regions x 5 frequencies). In general, few region-frequency pairs in MNI
and HUP significantly differed (Supplementary Figure 6.3). Therefore, we combined the
MNI atlas (1772 channels) with regions in the HUP cohort which we judged to be likely
clinically normal (858 channels), yielding a composite normative atlas total of 2630
channels for all subsequent analyses.
We then compared spectral features of the composite atlas against those of channels
in the irritative and seizure onset zones, and found that this process identifies a large
number of region-frequency pairs as significantly different (Supplementary Figure 6.4).
After correcting for 100 comparisons we identified 23 and 19 significantly different regionfrequency pairs for irritative and seizure onset zones respectively, validating this approach
to normative atlas mapping. However, this analysis could not identify potentially
epileptogenic channels in some of the most clinically relevant ROI. While abnormalities in
temporal and frontal neocortex were quantitatively evident, median spectral density in all
bands was similar in the combined amygdala-hippocampus region between channels in the
seizure onset zone and those judged as normal. Thus, additional features are required as
mesial temporal lobe epilepsy are some of the most important focal epilepsy syndromes
and often may significantly benefit from epilepsy surgery.
To complement spectral density in detecting abnormalities using normative atlas
mapping, we asked whether signal entropy significantly differed between clinically normal
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and abnormal channels. As values of wavelet entropy in our dataset are negative and
skewed, we plotted and analyzed log negative Shannon entropy (Supplementary Figure
6.5) so we may estimate normal distributions for subsequent analyses. Shannon wavelet
entropy is a commonly-used metric in quantitative EEG analysis that quantifies the level
of disorder in time-series signals. We expected that clinically abnormal channels would
generally have less disorder given that they may lose their normal function. Similar to
spectral density, we tested whether the distribution of entropy was significantly different
in each region between normal, irritative, and SOZ channels. We found that wavelet
entropy could distinguish irritative and seizure onset zones from normal particularly in
frontal ROI, and in particular could distinguish SOZ from both normal and irritative zones
in superior and middle frontal gyri. In these regions, log negative entropy was higher in
SOZ versus normal channels implying the seizure onset zone has signals that are more
ordered and that normal variability is interrupted. These findings suggest that entropy is
an effective metric for normative atlas mapping and may provide complementary
information to traditional spectral features.
6.4.2 Mapping abnormality with univariate versus bivariate features
To build upon mapping neural activity with univariate features, we then sought to
determine whether inter-regional activity abnormalities identify seizure onset zones using
the normative atlas. We first confirmed that HUP and MNI components of the normative
atlas provided similar quantifications of brain connectivity by examining the Pearson
correlation of their adjacency matrices (r = 0.43, p = 4.6e-19). We used the atlas to compute
within-patient connectivity and use edges between uninvolved channels to estimate
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normative distributions for each inter-regional connection. This process allowed us to
generate Z-scores for each connection and we took the maximum Z score across all 10
bivariate features and all 10 univariate features for each node. As clinical abnormalities in
the amygdala and hippocampus were not easily distinguished from normal by univariate
Z-scores, we first asked whether the seizure onset zone had abnormal connectivity when
located in the mesial temporal lobe (Figure 6.3A). We analyzed differences in Z-scores for
non-involved, irritative zone, and seizure onset zone separately for the maximum bivariate
and maximum univariate measure. We found that both the seizure onset zone and exclusive
irritative zone had significantly higher median connectivity abnormality compared to
normal channels when located amygdala or hippocampus (rank-sum p < 0.001). However,
as expected, we observed no significant difference in maximum univariate measures. This
finding confirms the importance of mapping not only abnormalities in activity but also
those in connectivity, and together with the previous univariate results suggests that
normative atlas mapping is able to detect abnormalities across the brain regardless of ROI.
We then asked whether patients with lesional imaging have higher abnormality than
those without lesions (Figure 6.3B). In patients with lesions on imaging, we found higher
bivariate abnormality within versus outside the SOZ (p < 0.001). The SOZ of lesional
subjects was higher than the SOZ of non-lesional subjects (p < 0.001), outside the SOZ of
lesional subjects was also more abnormal than outside the SOZ of non-lesional subjects (p
< 0.001). For univariate features, there was higher abnormality outside the SOZ compared
to within it for lesional subjects (p<0.001), whereas non-lesional subjects had higher
abnormality within (p<0.001) and outside the SOZ (p<0.05) compared to lesional subjects.
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These results demonstrate that lesions may affect widespread patterns of activity and
connectivity in different ways.

Figure 6.3. Maximum univariate and bivariate abnormality. (A) In the MTL, a
region in which univariate features performed poorly, connectivity features are higher
in abnormal regions (both EIZ and SOZ) compared to normal brain (rank-sum p <
0.001) however they cannot separate channels in the amygdala + hippocampus which
spike from those which generate seizures (rank-sum p = 0.4). Univariate features in this
region could not distinguish SOZ, EIZ, and uninvolved channels (B) In patients with
lesions on imaging, we found higher bivariate abnormality within versus outside the
SOZ (p < 0.001). The SOZ of lesional subjects was higher than the SOZ of non-lesional
subjects (p < 0.001), outside the SOZ of lesional subjects was also more abnormal than
outside the SOZ of non-lesional subjects (p < 0.001). For univariate features, there was
higher abnormality outside the SOZ compared to within it for lesional subjects
(p<0.001), whereas non-lesional subjects had higher abnormality within (p<0.001) and
outside the SOZ (p<0.05) compared to lesional subjects.

6.4.3 Clinical applications of normative atlas mapping
We sought to establish the potential clinical utility of iEEG atlas mapping. To
illustrate the approach, we highlight two clinical examples from patients with temporal
lobe epilepsy. Figure 6.4A shows a patient that achieved seizure freedom from surgery.
One electrode contact, in superior frontal gyrus, showed low levels of abnormality across
all features and clinically determined to be normal as well. Another in inferior frontal gyrus
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showed higher abnormality and localized to the irritative zone. A final electrode in
hippocampus showed the highest abnormality in alpha coherence, and was successfully
resected as part of the seizure onset zone. Figure 4B shows a patient which experienced a
reduction in seizures but not seizure freedom. Here, an irritative zone channel in middle
temporal gyrus had higher abnormality scores than a non-involved channel in middle
frontal gyrus, or a resected seizure onset zone channel in inferior temporal gyrus. Overall,
our approach represents a relatively intuitive method for mapping interictal abnormalities
that may not be evident from examining intracranial recordings directly.
We finally sought to quantify the accuracy with which atlas abnormality Z-scores
could distinguish seizure onset zone versus normal brain. Using Z-scores from all 20
features we trained a random forest classifier, chosen for its ease of training and robustness
to correlated features, and quantified performance using 10-fold cross validation. This
process achieved an AUC of 0.81, versus AUC of 0.79 and 0.73 for only univariate and
only bivariate features respectively (Figure 6.4C). These results represent good
classification performance showing that normative mapping scores can interictally
distinguish SOZ from normal channels.
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Figure 6.4. Clinical application of abnormality mapping. (A) In a good surgical
outcome patient, we show resection zone, irritative zone, and uninvolved zone on the
left. One electrode contact, in superior frontal gyrus, showed low levels of abnormality
across all features and clinically determined to be normal as well. Another in inferior
frontal gyrus showed higher abnormality and localized to the irritative zone. A final
electrode in hippocampus showed the highest abnormality in alpha coherence, and was
successfully resected as part of the seizure onset zone. (B) In a poor outcome patient,
an irritative zone channel in middle temporal gyrus had higher abnormality scores than
a non-involved channel in middle frontal gyrus, or a resected seizure onset zone channel
in inferior temporal gyrus. (C) We cross-validated a random forest model using both
univariate and bivariate features for predicting seizure onset zone versus uninvolved
brain. We found an AUC of 0.81 which was higher than either using only univariate
features (AUC = 0.79) or only bivariate features (AUC = 0.73).

6.5 Discussion
In this study we construct and validate an iEEG atlas, illustrating its potential utility
towards data-driven mapping of abnormal brain regions in epilepsy. By comparing features
of activity and connectivity in test subjects to those of putatively normal brain, we reliably
identify clinically abnormal regions such as the seizure onset zone. We show that lesional
patients have a higher level of overall abnormality than non-lesional patients, that in
different ROI the seizure onset zone may be identified from normal brain by unique
features, and that abnormalities in functional connectivity are particularly useful for
identifying mesial temporal lobe SOZs. Finally, we publicly share our validated iEEG atlas
containing both normal and abnormal channels to allow others to build upon our methods.
Developing new interventions for patients with drug-resistant seizures requires a
better understanding of the relationship between the abnormal brain and epilepsy. While
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distinct epilepsy syndromes and etiologies may result in different electrographic seizure
onset patterns19, recognizing their impact on interictal activity is more difficult. For our
current study in which we probe quantitative abnormality of uninvolved, irritative, and
seizure onset zones, we find that univariate spectral content is most useful in temporal and
frontal neocortex, entropy is useful in frontal cortex, and connectivity is useful in mesial
temporal lobe. Thus, the ability of normative atlas mapping to leverage different
quantitative metrics in a single, flexible framework may allow it to serve as a generalizable
tool that works in many clinical scenarios. It is unlikely that abnormalities that underlie
seizure onset regions across the brain manifest a single, unified characteristic. Furthermore,
our finding that univariate and bivariate measures provide complementary information
light on an important debate in epilepsy surgery: It is not always clear whether epilepsy
should be viewed as a focal problem within a network (and thus probed by univariate
methods) or as a broader, integrated network disorder (and thus studied through
connectivity)191. Our atlas provides methods for assessing the extent of each of these
hypotheses and whether certain patients may have pathology that is predominantly focal or
distributed.
Our study adds to a growing body of work on normative atlas analysis for
intracranial EEG. We directly build upon the work of Frauscher et al. 2018, in which they
demonstrated the approach of aggregating curated normative data and showed that spectral
features including peak frequencies differ throughout cortical regions. Our extension
demonstrates that this technique can indeed detect abnormality. We also adapt multipatient functional connectivity approaches from Betzel et al., 2018, in which they
140

demonstrated that integrating adjacency matrices across patients provides group-level
ECoG connectivity that closely mirrors functional MRI connectivity. Here, we have
confirmed that deviations from expected, normative connectivity indeed can distinguish
potentially epileptogenic regions. Overall, our work of normative mapping is closest in
methodology to Taylor et al., 2021 in which they use an atlas approach of univariate
spectral features to identify epileptogenic regions by Z-score as we have. However, besides
confirming aspects of their results on a completely separate dataset we also extend this by
showing the utility of other univariate features such as entropy and that connectivity may
improve the overall approach. Ultimately, the large, multi-center nature of these efforts
including ours may lay the groundwork for normative iEEG mapping to serve as an
important clinical tool in the near future.
6.5.1 Limitations & future directions
Our study represents a significant foray into using full-brain atlas approaches of
iEEG to guide epilepsy surgery, but comes with several limitations. One of these is that the
assumption of normal activity and connectivity in uninvolved regions may not be
universally valid. For example, uninvolved regions may exert inhibitory activity on a
seizure focus as part of an inhibitory surround and could have abnormal activity as a result
of this. Indeed, even in good outcome patients, abnormalities in structural connectivity are
observed outside of the resection zone186 and may not be significant enough to cause
seizures. Future work and data sharing across centers could permit the incorporation of
patients that received iEEG for purposes such as facial pain192 or other conditions in which
no epileptic foci exist.
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Another significant limitation is the spatial scale at which we map activity and
connectivity. In this study we focus on connectivity between gross anatomic regions, while
many of the aberrations in connectivity exist within ROI and thus could not be probed by
our current approach. However, the natural step would be to break up AAL regions into
even smaller parcellations, and such atlases of up to 600 regions have been used by our
group in different contexts193. Even with 166 patients which represents one of the largest
published patient cohorts in a computational iEEG study, we did not have dense enough
coverage in every region to have greater spatial granularity. However, as we show the
power of building upon previously established datasets, we hope for others to further build
upon our normative atlas mapping which could allow this approach to be taken in the
future. This step could also ensure that all possible connections in the functional
connectivity atlas are represented and have sufficient samples for the median and variance
in connectivity to be more accurately estimated.
To expand the utility of our atlas of iEEG connectivity epilepsy surgery, the natural
next step is to join our approach with similar methods in neuroimaging. Doing so may
allow for identifying abnormal connections in regions that aren’t typically implanted by
iEEG such as central gray matter structures including the thalamus which is implicated in
seizure generation and propagation. Furthermore, combining our approach with DTI could
help answer whether functional connectivity abnormalities as measured by iEEG are highly
correlated to structural abnormalities, or whether these phenomena are only loosely related.
Using full-brain iEEG atlas approaches could enable clinicians to better understand the
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relationship between structure and function and might ultimately allow iEEG to be replaced
with fully non-invasive studies in some patients.
6.5.2 Conclusions
In conclusion, we have demonstrated the feasibility of using an atlas of iEEG for
brain mapping in patients with drug-resistant epilepsy undergoing surgical evaluation. We
validate the concordance of a multi-center atlas, and illustrate that clinically abnormal
regions including seizure onset zone and irritative zone are detectable by Z-score. We show
that connectivity augments univariate measures of activity, particularly in the mesial
temporal lobe, and show good classification of seizure onset zone versus normal channels.
Through extensive data sharing we may soon reach adequate accuracy and brain coverage
to use the atlas method as a preferred approach as a quantitative method for identifying the
epileptogenic zone from intracranial EEG which could offer a substantial improvement for
epilepsy surgery outcomes.
6.6 Supplemental Materials
Supplemental Methods 1: Wake/Sleep Classification.
In many intracranial EEG (iEEG) patients at the Hospital of the University of Pennsylvania
(HUP), we did not have simultaneous scalp EEG and/or adequate clinical staging of sleep.
Thus, we needed to develop a sleep detector based on only iEEG signals. We used the data
from Montreal Neurological Institute to train a detector of NREM sleep based on
bandpower in the canonical frequency bands (delta: 0.5-4 Hz, theta: 4-8 Hz, alpha 8-13 Hz,
beta 13-30 Hz). We used a logistic regression model and achieved 0.90 AUC on a perchannel basis in the MNI dataset. In a subset of our patients, limited clinical sleep
annotations were available. We tested the accuracy of our sleep detector in these patients,
and found a performance of 0.77 AUC on a per-channel basis and 0.80 AUC on a per-time
basis. We also selected time windows during normal waking hours where possible (8 am –
8 pm) to minimize the effects of any misclassification on the part of the NREM sleep
detector.
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cross-validation ROC for NREM sleep detection
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Supplementary Figure 6.1. Cross-validation receiver operating characteristic for
NREM sleep detector. Area under the receiver-operating characteristic curve on crossvalidation is 0.90.
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Structure name
wake_clip

Rows
12000 = samples
(60 seconds at
200 Hz)
3431 = channels

Columns
3431 channels

Unit/descriptor
iEEG data in bipolar
montage, filtered 0.580 Hz
mni_coords
3 coordinates
MNI-152 coordinates
(X,Y,Z)
of each bipolar
centroid
patient_no
3431 = channels
1
Patient number for
each channel
resected_ch
3431 = channels
1
Whether or not each
channel was
resected/ablated (1 =
resected/ablated)
soz_ch
3431 = channels
1
Whether or not each
channel was in the
seizure onset zone (1 =
within SOZ)
spike_24h
3431 = channels
1
Estimated spike rate
per 24 hours (we
defined irritative zone
as spike_24h>24)
Supplementary Table 6.1. Data fields for the HUP iEEG Open Atlas. The Matlab
file contains the structures listed in the leftmost column. Rows and columns of each
matrix are described above.

145

Supplementary Figure 6.2. Reduced AAL atlas. (A) In the original 90 regions of noncerebellar AAL atlas, we eliminated regions which had very few channels, and
combined others to reduce the total number of ROI and increase the samples per region.
(B) A rendering of the ROI in our reduced atlas.
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Supplementary Figure 6.3: Normal power spectra in HUP vs MNI. Blue: MNI,
Green: HUP. * = p < 0.0005 as we corrected for 100 comparisons. In most regions,
power spectral density between HUP and MNI atlases were similar and thus we
combined them into a composite atlas.
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Supplementary Figure 6.4: Power spectra in irritative and seizure onset zone
versus normative composite atlas. Blue: Composite normative atlas, Green: Irritative
zone, Red: Seizure onset zone. * = p < 0.0005 as we corrected for 100 comparisons.
The * is located above the Greek letters indicating frequency band if SOZ vs. composite
atlas is significant, and below the Greek letters if irritative zone vs. composite atlas is
significant.
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Supplementary Figure 6.5: Entropy in irritative and seizure onset zone versus
normative composite atlas. Blue: Composite normative atlas, Green: Irritative zone,
Red: Seizure onset zone. * = p < 0.0005 as we corrected for 100 comparisons. We are
plotting log negative entropy here and use that in our atlas as it approaches a normal
distribution that can be estimated more accurately. Higher values correspond to signals
that are more ordered (and therefore less entropy)
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CHAPTER 7: Conclusions and Future Directions
In this thesis, I developed and validated methods for the quantitative localization of
the epileptogenic zone from intracranial EEG. These methods, which leverage both
interictal and ictal data could eventually serve as supplementary biomarkers during
epilepsy surgical evaluation. Overall, I have made the following contributions with this
dissertation:
Contribution 1: Methods for simulating different surgical approaches and outcome
prediction
The virtual resection method is a flexible, data-driven framework for pre-surgical
prognostication using the change of synchronizability at seizure onset as a network
biomarker of surgical outcome. Control centrality can serve as a method to simulate
different interventions and select the surgical approach most likely to render the patient
seizure free. Furthermore, I have validated that virtual resection can reveal subtle aspects
of seizure dynamics that are not evident from traditional evaluation of onset patterns.
Contribution 2: Methods for assessing the impact of sampling bias
One of the primary limitations in deploying network models as clinical tools is the
interaction between which and how many brain regions are sampled and the values of
different metrics. From the work presented here, we now have ways of accounting for
sampling bias, such as using jackknife resampling as in Chapter 4. Furthermore, I also
show that correcting for electrode type and internodal distance as in Chapter 5 can help
mitigate bias introduced by differences in ECoG and SEEG though the epileptogenic zone
still has distinct characteristics in patients which underwent resection versus ablation.
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These tools will be essential in the future study and eventual clinical deployment of iEEG
network models.
Contribution 3: An intracranial EEG atlas for assessing abnormalities in neural
activity and connectivity
Another major limitation of previous work is that there are no healthy controls with
iEEG so it is difficult to estimate what normal activity and connectivity should be
throughout the brain. By aggregating and carefully selecting channels without spikes,
seizure onset zones, and other abnormalities, I developed an iEEG atlas and validated it
against a similar dataset published by another center. I also provide methods for probing
the relationship between activity and connectivity by mapping the abnormality of each
node. This approach is likely to become even more powerful as datasets get larger over
time.
Contribution 4: Open source data and code
Epilepsy surgery and intracranial EEG is highly specialized and is only available at
a relatively small number of hospitals worldwide. Even at these centers, clinical volumes
are not high, therefore the amount of data that any one research group can access is
typically too small to account for the high level of variability across patients. Therefore,
extensive data-sharing efforts are required to advance quantitative iEEG towards clinical
practice. As part of this thesis, we are releasing full datasets from over 60 patients,
including imaging and clinical metadata, which may serve as the ‘gold-standard’ dataset
for future studies. I am also releasing code associated with each method found in this
dissertation so that others may build upon our efforts.
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Future directions
The work presented in this thesis provides the foundation for multiple areas of
future research. One important direction, built upon the work of Chapter 3 could use the
framework of synchronizability and control centrality to understand why some seizures
generalize and others do not, and determine how long before seizures synchronizability
elevates from its baseline levels. Another important direction is extending the iEEG atlas
framework presented in Chapter 6 to other periods of time, such as during sleep, or before
seizures. Overall, many of the methods I have developed must also be compared and
contrasted with findings form quantitative image analysis including diffusion imaging and
functional MRI in order to gain some information about epileptic networks non-invasively.
Finally, we must construct hardware and software to allow for the real-time deployment of
these models in a clinical setting to allow for trials to translate these methods from bench
to bedside.
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